number: vol 18 no. 112 date released: october 21, 2015

Intellectual Property Center, 28 Upper McKinley Rd. McKinley Hill Town Center, Fort Bonifacio, Taguig City 1634 Philippines

Tel. No. 238-6300 Website: http://www.ipophil.gov.ph e-mail: [email protected] Number: VOL 18 NO. 112

Date Released: October 21, 2015 1 INVENTIONS ............................................................................................................................................................................. 2

1.1 FORFEITED INVENTION APPLICATIONS ........................................................................................................................... 2



Date Released: October 21, 2015

1 INVENTIONS

1.1 FORFEITED INVENTION APPLICATIONS

No. Application Number Date Filed Date

Forfeited Title Applicant Attorney / Agent

1 1/2001/000082 17/01/2001 20/10/2015

COMBINATION OF BIOLOGICAL AND

CHEMICAL RODENT CONTROL

BAYER AKTIENGESELLS

CHAFT

ORTEGA DEL CASTILLO BACORRO

ODULIO CALMA AND CARBONELL

2 1/2004/000309 27/07/2004 20/10/2015 HERBAL MEDICINES

NUTRITIONAL WHITENING SOAP

PEREZ, PEPE EPIFANIO L [PH]

3 1/2004/000516 18/11/2004 20/10/2015 PODPOD (SMOKED FISH CAKE)

LOMBRIO, REYNALDO A

[PH]

4 1/2004/000557 13/12/2004 20/10/2015

IMPROVED PROCESS OF BREWING WINE FROM GLUTINOUS

MILLED RICE

PHILIPPINE RICE RESEARCH

INSTITUTE [PH]

5 1/2004/500493 05/04/2004 20/10/2015

METHODS OF TREATING LIVER

FIBROSIS AND HEPATITIS C VIRUS

INFECTION

INTERMUNE, INC. [US]

VERALAW (DEL ROSARIO

BAGAMASBAD AND RABOCA)

6 1/2004/501297 25/08/2004 20/10/2015

CO-THERAPY FOR THE TREATMENT OF

MIGRAINE COMPRISING

ANTICONVULSANT DERIVATIVES AND

ANTI-MIGRAINE AGE

ORTHO-MCNEIL PHARMACEUTIC

AL, INC. [US]

ROMULO MABANTA

BUENAVENTURA SAYOC AND

DELOS ANGELES

7 1/2004/501656 14/10/2004 20/10/2015

COMBINATION THERAPY FOR THE

TREATMENT OF CANCER

SLOAN-KETTERING

INSTITUTE FOR CANCER

RESEARCH [US]

DEL ROSARIO BAGAMASBAD &

RABOCA

8 1/2005/000222 04/05/2005 20/10/2015

2-OXO-1-PYRROLIDINE DERIVATIVES

PROCESS FOR PREPARING THEM AND

THEIR USES

UCB FARCHIM S.A. (AG-LTD.),

[BE]

SIGUION REYNA MONTECILLO

AND ONGSIAKO

9 1/2005/000256 24/05/2005 20/10/2015 A PROCESS TO

PRODUCE HYBRID CELLULAR FUELS FROM CELLULOSE

EAMIGUEL, ARTURO G [PH]

OSCAR M. MANAHAN

10 1/2005/000280 03/06/2005 20/10/2015 THE MOJICA NON-

BIOLOGICAL COCONUT PROCESS

MOJICA, JR., ISAAC N [PH]

11 1/2005/000385 02/08/2005 20/10/2015 NON-ESSENTIAL AMINO ACIDS

INNOGENE KALBIOTECH

A.Q. ANCHETA AND PARTNERS




CONTAINING PHARMACEUTICAL COMPOSITION AND

USES THEREOF

PTE. LTD., [SG]

12 1/2005/502049 11/11/2005 20/10/2015 DETERMINATION OF

AROMATIC HYDROCARBONS IN

EDIBLE OIL PRODUCTS

CARGILL, INCORPORATED

[US]

ROMULO MABANTA


DELOS ANGELES

13 1/2006/000367 26/07/2006 20/10/2015 AN EGG SHELF-LIKE QUALITY ENHANCER

SOLUTION

SANGUTAN, VIRGILIO M. [PH]

ONOFRE A. FRANCISCO, JR.

14 1/2006/000399 16/08/2006 20/10/2015

SHELF STABLE ACIDIFIED FOOD

COMPOSITIONS AND METHODS FOR THEIR

PREPARATION

KRAFT FOODS GROUP BRANDS

LLC [US]

SYCIP SALAZAR HERNANDEZ AND

GATMAITAN

15 1/2006/500628 27/03/2006 20/10/2015

SUBSTITUTED BENZAZOLES AND USE

THEREOF AS INHIBITORS OF RAF

KINASE

CHIRON CORPORATION

[US]


GATMAITAN

16 1/2006/501673 25/08/2006 20/10/2015 FLAVIVIRUS VACCINES ACAMBIS, INC. [US]

SAPALO VELEZ BUNDANG &

BULILAN LAW OFFICES

17 1/2006/501678 28/08/2006 20/10/2015 NEW COMPOUNDS

FOR THE INHIBITION OF ANGIOGENESIS

AND USE OF THEREOF

JERINI AG [DE] SIGUION REYNA

MONTECILLO AND ONGSIAKO

18 1/2006/501693 31/08/2006 20/10/2015 USE OF ORGANIC COMPOUNDS

NOVARTIS AG [CH]

E.B. ASTUDILLO AND ASSOCIATES

19 1/2007/000123 30/03/2007 20/10/2015

PROCESS FOR PRODUCING

MONOLAURIN FROM COCONUT C12 FATTY

ACID

INDUSTRIAL TECHNOLOGY

DEVELOPMENT INSTITUTE [PH]

OLIVIA P. CRUZ

20 1/2007/000168 27/04/2007 20/10/2015

METHOD OF PRODUCING

FORGINGS HAVING EXCELLENT TENSILE

STRENGTH AND ELONGATION FROM STEEL WIRE RODS

FWU KUANG ENTERPRISES

CO., LTD., [TW]


21 1/2007/000355 07/09/2007 20/10/2015 MICROWAVABLE FOOD PRODUCTS

KRAFT FOODS HOLDINGS, INC.

[US]


GATMAITAN

22 1/2007/000360 14/09/2007 20/10/2015 FOOD INGREDIENTS

WITH REDUCED SOURNESS AT LOW PH


[US]


GATMAITAN

23 1/2007/000407 03/10/2007 20/10/2015

USE OF ERYTHRITOL AND D-TAGATOSE IN DIET OR REDUCED-

CALORIE BEVERAGES AND FOOD PRODUCTS

PEPSICO, INC. [US]

ATTY. CHITO B. DIMACULANGAN

24 1/2007/500057 05/01/2007 20/10/2015 MULTIVALENT VLA-4

ANTAGONISTS COMPRISING

ELAN PHARMACEUTIC

ALS, INC. [US]

ROMULO MABANTA

BUENAVENTURA




POLYMER MOIETIES SAYOC AND DELOS ANGELES

25 1/2007/500429 21/02/2007 20/10/2015 METHOD FOR THE

TELOMERIZATION OF NON-CYCLIC OLEFINS

EVONIK OXENO GMBH [DE]

ORTEGA DEL CASTILLO

BACORRO CALMA & CARBONELL

26 1/2007/501012 11/05/2007 20/10/2015 NEMATICIDAL COMPOSITIONS

DEVGEN N.V. [BE]

VERA LAW (DEL ROSARIO RABOCA

GONZALES GRASPARIL)

27 1/2007/501053 17/05/2007 20/10/2015

COMPOSITIONS COMPRISING SCYLLO-

INOSITOL DERIVATIVES AND

METHODS TO TREAT DISORDERS OF

PROTEIN AGGREGATION

MCLAURIN, JOANNE [CA] SANKAR, SABITA

28 1/2007/501088 22/05/2007 20/10/2015

HIGH-CLEANING SILICA MATERIALS MADE VIA

PRODUCT MORPHOLOGY CONTROL AND

DENTIFRICE CONTAINING SUCH

J.M HUBER CORPORATION

[US]

VILLARAZA CRUZ MARCELO & ANGANGCO

29 1/2007/501255 15/06/2007 20/10/2015

METHOD OF TREATING WASTEWATER

CONTAINING ORGANIC COMPOUND

IBIDEN CO., LTD. [JP]

ROMULO MABANTA

BUENAVENTURA SAYOC & DE LOS

ANGELES

30 1/2007/501287 20/06/2007 20/10/2015 ANTI-IL-12 ANTIBODIES,

EPITOPES, COMPOSITIONS,

METHODS AND USES

CENTOCOR, INC [US]

ROMULO MABANTA


DELOS ANGELES

31 1/2007/501347 22/06/2007 20/10/2015 PROCESS FOR THE

MANUFACTURE OF 1,2-DICHLOROETHANE

SOLVAY (SOCIETE

ANONYME ) [BE]

ROMULO MABANTA


DELOS ANGELES

32 1/2007/501452 06/07/2007 20/10/2015


TREATMENT OF DIABETES AND

CONDITIONS RELATED THERETO AND FOR

THE TREATME

ARENA PHARMACEUTIC

ALS INC. [US]

COCHINGYAN & PERALTA LAW

OFFICES

33 1/2007/501631 27/07/2007 20/10/2015

PHARMACEUTICAL COMPOSITION FOR

THE TREATMENT OR PREVENTION OF

DISEASES INVOLVING OBESITY, DIABETES,

KT & G CO., LTD., [KR] AND MD

BIOALPHA CO., LTD. [KR]


34 1/2007/502100 25/09/2007 20/10/2015 PHARMACOKINETICALL

Y IMPROVED COMPOUNDS

SURFACE LOGIX, INC. [US]

BUCOY POBLADOR & ASSOCIATES




35 1/2007/502169 02/10/2007 20/10/2015 PREVENTIVE OR

REMEDY FOR DEPRESSION OR

ANXIETY NEUROSIS

TAKEDA PHARMACEUTIC

AL COMPANY LIMITED [JP]



36 1/2007/502241 11/10/2007 20/10/2015

USE OF AZITHROMYCIN FOR

THE PRODUCTION OF A MEDICAMENT FOR

TREATMENT OF OCULAR INFECTIONS

LABORATORIES THEA, [FR]

NORBERTO S. GONZALES & ASSOCIATES

37 1/2007/502297 17/10/2007 20/10/2015 C. PERFRINGENS

ALPHA TOXOID VACCINE

SCHERING PLOUGH LTD

[CH] HECHANOVA &

CO., INC.

38 1/2007/502513 09/11/2007 20/10/2015

3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-

PYRIDAZINO[4,5-B]INDOLE-1-ACETAMIDE

DERIVATIVES, THEIR PREPARATION

SANOFI- AVENTIS [FR]

SALUDO FERNANDEZ AND

AQUINO (SAFA LAW)

39 1/2007/502517 12/11/2007 20/10/2015

A METHOD OF MARKING A

COMPOSITION FOR USE IN ORAL

ADMINISTRATION

EISAI R & D MANAGEMENT CO., LTD. [JP]

FEDERIS AND ASSOCIATES LAW OFFICES

40 1/2007/502552 15/11/2007 20/10/2015

TREATMENT OF KERATINOUS

DRYNESS WITH GLYCERIDES

LABORATOIRES INNEOV, [FR]

ROMULO MABANTA


DELOS ANGELES

41 1/2007/502557 15/11/2007 20/10/2015

UREA-COMPOUNDS ACTIVE AS VANILLOID

RECEPTOR ANTAGONISTS FOR THE TREATMENT OF

PAIN

SMITHKLINE BEECHAM P.L.C.

[UK]


42 1/2007/502559 15/11/2007 20/10/2015 COMPOUNDS FOR

ORGANIC ELECTRONIC DEVICES

MERCK PATENT GMBH [DE]


43 1/2007/502612 20/11/2007 20/10/2015 CONTINUOUS METHOD

FOR PREPARING CHLOROHYDRINS

SOLVAY S.A. [BE]

ROMULO MABANTA


DELOS ANGELES

44 1/2007/502759 05/12/2007 20/10/2015 PROCESS OF

PRODUCING BLEACH BOOSTERS

BASF AKTIENGESELLS

CHAFT [DE] E.B. ASTUDILLO

AND ASSOCIATES

45 1/2007/502864 17/12/2007 20/10/2015

THERMOPLASTIC POLYMER

COMPOSITIONS INCLUDING SILICA-

CONTAINING NUCLEATING AGENTS

BEAULIEU GROUP, LLC

D/B/A/ BEAULIEU OF AMERICA,

[US]

CHAN ROBLES & ASSOCIATES

46 1/2008/000001 02/01/2008 20/10/2015 QUANTUM MINERALS PLUS

MACEDA-PATAWARAN,

DELIA [PH]




47 1/2008/000008 09/01/2008 10/09/2015

METHOD AND USE AS HEALTH TONIC DRINK USING LIQUID PLANT EXTRACT OF MUSA

DIZON, DANTE C [PH] AND DIZON, RODOLFO L [PH]

48 1/2008/000086 13/03/2008 20/10/2015 A STERILIZATION

PROCESS FOR PLANT PARTS WITH A NOVEL

COOKING SYSTEM

LIM, CHAN LOCK [MY]

CASTILLO LAMAN TAN PANTALEON & SAN JOSE LAW

OFFICES

49 1/2008/000137 25/04/2008 20/10/2015 WONDER FLOUR CUEVAS, ANTONIO

NELSON E [PH]

50 1/2008/000139 25/04/2008 20/10/2015

A PROCESS TO CREATE COLORFUL GRAPHIC DESIGNS,

IMAGES, PATTERNS IN AN ANODIZED ALUMINUM OR

ALUMINUM ALLOY SURFACE

DR. RONALD S. DE LOS REYES

[PH]

51 1/2008/000174 21/05/2008 20/10/2015

METHOD TO DETECT SOIL NUTRIENT

DEFICIENCY AND BALANCING FERTILIZER

APPLICATION, KIT AND USE THEREOF

PHILIPPINE RICE RESEARCH

INSTITUTE [PH] JERRY C.

SERAPION

52 1/2008/000183 27/05/2008 20/10/2015 A METHOD OF

VACUUM FREEZE DRYING SQUID CHIPS

LEE, YOONSUNG [KR] AND KIM, HYUNGIK [KR]

MANUEL C. CASES, JR. AND

ASSOCIATES

53 1/2008/000211 24/06/2008 20/10/2015

COSMETIC COMPOSITION CONTAINING

PANCREATIC ENZYME

JOHN SYLORIA [PH]

HECHANOVA AND CO. INC.

54 1/2008/000238 14/07/2008 20/10/2015 K-V10 2T OIL

NATIONAL RESEARCH

COUNCIL OF THE

PHILIPPINES [PH]

FELIPE RONALD M. ARGAMOSA

55 1/2008/000250 18/07/2008 20/10/2015 METHOD FOR DECORATING

SURFACES

EVONIK DEGUSSA

GMBH, [DE]


56 1/2008/000470 19/12/2008 20/10/2015

METHOD OF TREATING METABOLIC DISORDERS, ESPECIALLY

DIABETES, OR A DISEASE OR CONDITION

ASSOCIATED WITH DIABETES

NOVARTIS AG, [CH]


57 1/2008/500051 07/01/2008 20/10/2015

METHODS AND COMPOSITIONS FOR

TREATING OPHTHALMIC

CONDITIONS VIA SERUM RETINOL, SERUM RETINOL

REVISION THERAPEUTICS,

INC. [US]


BULILAN LAW OFFICES




BINDING PROTEIN (RBP), AND/OR SERUM

RETINOL-RBP MODULATION

58 1/2008/500066 08/01/2008 20/10/2015 AN OXIME DERIVATIVE AND PREPARATIONS

THEREOF

MITSUBISHI TANABE PHARMA

CORPORATION [JP]


GATMAITAN

59 1/2008/500068 08/01/2008 20/10/2015 PROMOTION OF

EPITHELIAL REGENERATION

RENOVO LTD [GB]


60 1/2008/500109 15/01/2008 20/10/2015

INTERACTION OF MORAXELLA

CATARRHALIS WITH EPITHELIAL CELLS, EXTRACELLULAR

MATRIX PROTEINS AND THE CO

ARNE FORSGREN AB,

[SE]


AND ONGSIAKO

61 1/2008/500151 21/01/2008 20/10/2015 DIETARY FIBER

FORMULATION AND METHOD OF

ADMINISTRATION

NESTEC S.A. [CH]

SIGUION REYNA MONTECILLO & ONGSIAKO LAW

OFFICES

62 1/2008/500168 21/01/2008 20/10/2015

SOLID DOSAGE FORMS OF VALSARTAN AND

AMLODIPINE AND METHOD OF MAKING

THE SAME

NOVARTIS AG [CH]


63 1/2008/500293 04/02/2008 20/10/2015 STABILIZERS FOR

VETERINARY VACCINES

WYETH [US] CASTILLO LAMAN TAN PANTALEON & SAN JOSE LAW

OFFICES

64 1/2008/500294 04/02/2008 20/10/2015 CORN PROTEIN CONCENTRATES

CARGILL, INCORPORATED

[US]


OFFICES

65 1/2008/500298 04/02/2008 20/10/2015 APPARATUS FOR

CONCENTRATING A NEBULANT

SABAN VENTURES PTY

LIMITED [AU]


OFFICES

66 1/2008/500388 13/02/2008 20/10/2015

MODULATORS OF METABOLISM AND THE

TREATMENT OF DISORDERS RELATED

THERETO

ARENA PHARMACEUTIC

ALS, INC. [US]

COCHINGYAN & PERALTA LAW

OFFICES

67 1/2008/500422 18/02/2008 20/10/2015

CHEMICAL PROCESS FOR THE

PREPARATION OF BENZOXAZOLE

DERIVATIVES USED AS PESTICIDES

SYNGENTA LIMITED [GB]


68 1/2008/500448 22/02/2008 20/10/2015 THIOMORPHOLINE COMPOUND AND PROCESS FOR

PREPARING THE SAME


CORPORATION [JP]


69 1/2008/500504 29/02/2008 20/10/2015 A USE OF SULFONANILIDES AS

BAYER CROPSCIENCE

CESAR C. CRUZ & PARTNERS




HERBICIDE AG [DE]

70 1/2008/500554 06/03/2008 20/10/2015 CONDUCTIVE HYDROCARBON FLUID

SAINT-GOBAIN CERAMICS &

PLASTICS, INC., [US]

LAGUNA LAKE TRADE MARKS

71 1/2008/500687 18/03/2008 20/10/2015 PLANT PATHOGENIC DEFENCE INCREASE

BAYER CROPSCIENCE

AG [DE]



72 1/2008/500701 19/03/2008 20/10/2015 ESTER COMPOUND AND MEDICAL USE

THEREFOR

JAPAN TOBACCO INC.

[JP]



73 1/2008/500702 19/03/2008 20/10/2015 ESTER COMPOUND

AND MEDICINAL USE THEREFOR

JAPAN TOBACCO INC.

[JP]



74 1/2008/500732 25/03/2008 20/10/2015

METHOD FOR TREATMENT AND PREVENTION OF

OTITIS MEDIA USING CHEMICAL

PENETRATION ENHANCERS TO

FACILITA

PIEDMONT PHARMACEUTIC

ALS LLC [US]



75 1/2008/500793 02/04/2008 20/10/2015

PREPARATION AND USE OF

TETRAHYDROPYRROLO [3,2-C] PYRIDIN-4-

ONE DERIVATIVES FOR TREATMENT OF

OBESITY,

ASTRAZENECA AB [ES]


OFFICES

76 1/2008/500816 04/04/2008 20/10/2015

USE OF PYRAZOLO[1,5-A] PYRIMIDINES

DERIVATIVES FOR INHIBITING PROTEIN KINASES METHODS

FOR INHIBITING

MERCK SHARP & DOHME CORP.

[US]

HECHANOVA & CO., INC.

77 1/2008/500831 08/04/2008 20/10/2015 SOLUTION FOR PRESERVING LIVER

OTSUKA PHARMACEUTIC

AL FACTORY, INC. [JP]


AND ONGSIAKO

78 1/2008/500941 21/04/2008 20/10/2015 AGENTS FOR

TREATING CARDIOPATHY

CHUGAI SEIYAKU

KABUSHIKI KAISHA [JP]


BULILAN LAW OFFICES

79 1/2008/500986 25/04/2008 20/10/2015

ARYLSULFONYLCHROMANS AS 5-HT6

INHIBITORS INDOLYLMALEIMIDE

DERIVATIVES AS PROTEIN KINASE

INHIBITORS

F. HOFFMAN - LA ROCHE AG [CH]


GATMAITAN




80 1/2008/501009 28/04/2008 20/10/2015 DIARYL UREAS FOR

TREATING PULMONARY

HYPERTENSION

BAYER HEALTHCARE

AG [DE]



81 1/2008/501037 02/05/2008 20/10/2015 TREATMENT OF STRESSED PATIENTS

NESTEC S.A. [CH]


AND ONGSIAKO

82 1/2008/501067 06/05/2008 20/10/2015

STABLE PHARMACEUTICAL

FORMULATIONS CONTAINING

ESCITALOPRAM AND BUPROPION

H. LUNDBECK A/S [DK]


83 1/2008/501109 09/05/2008 20/10/2015

DIARYL UREA FOR TREATING

PULMONARY HYPERTENSION

BAYER HEALTHCARE

AG [DE]



84 1/2008/501160 15/05/2008 20/10/2015

1,1-DIOXO-THIOMORPHOLINYL

INDOLYL METHANONE DERIVATIVES FOR USE

AS H3 MODULATORS

F. HOFFMAN-LA ROCHE AG [CH]


GATMAITAN

85 1/2008/501188 19/05/2008 20/10/2015 AQUEOUS

SUSPENSION CONCENTRATES

BAYER CROPSCIENCE

AG [DE] SANKAR, SABITA

86 1/2008/501201 20/05/2008 20/10/2015 NEW COMBINATION DOSAGE FORMS

ASTRAZENECA A.B. [SE]

ORBOS CABUSORA TAGUIAM

87 1/2008/501218 21/05/2008 20/10/2015

MODIFIED AND PULSATILE RELEASE

PHARMACEUTICAL FORMULATIONS OF

ESCITALOPRAM



88 1/2008/501259 27/05/2008 20/10/2015

POLYMER COMPOSITION HAVING

A HIGH REFRACTIVE INDEX

CORONIS GMBH, [DE]


89 1/2008/501324 04/06/2008 20/10/2015 CELLULOSE GEL FORMULATIONS

FMC CORPORATION

[US] JDF LAW

90 1/2008/501336 04/06/2008 20/10/2015

FOAM WAFER CONTAINING A

POLYVINYL ALCOHOL-POLYETHYLENE GLYCOL GRAFT

POLYMER

LTS LOHMANN THERAPIE-

SYSTEME AG [DE]


ASSOCIATES

91 1/2008/501407 12/06/2008 20/10/2015 DIPHENYL UREA DERIVATIVES

ARPIDA AG, [CH]


92 1/2008/501412 12/06/2008 20/10/2015

USE OF KCNQ-OPENERS FOR THREATING OR REDUCING THE SYMPTOMS OF

SCHIZOPHRENIA



93 1/2008/501426 13/06/2008 20/10/2015 USE OF BENZO-FUSED HETEROCYCLE

JANSSEN PHARMACEUTIC

ROMULO MABANTA




SULFAMIDE DERIVATIVES FOR THE

TREATMENT OF SUBSTANCE ABUSE

AND ADDICT

A N.V. [BE] BUENAVENTURA SAYOC AND

DELOS ANGELES

94 1/2008/501487 19/06/2008 20/10/2015

THROMBIN RECEPTOR ANTAGONISTS AS PROPHYLAXIS TO

COMPLICATIONS FROM CARDIOPULMONARY

SURGERY

SCHERING CORPORATION

[US]


GATMAITAN

95 1/2008/501527 20/06/2008 20/10/2015 A CURABLE EPOXY

RESIN COMPOSITION AND LAMINATES MADE

THEREFROM

DOW GLOBAL TECHNOLOGIES

INC. [US]



96 1/2008/501537 23/06/2008 20/10/2015 METHOD AND DEVICE

FOR RELEASING A PERFUME OR SCENT

V. MANE FILS [FR]


97 1/2008/501538 23/06/2008 20/10/2015 MASKING THE TASTE OF POWDERS

BAYER INTELLECTUAL

PROPERTY GMBH [DE]



98 1/2008/501572 27/06/2008 20/10/2015 CONTROLLED

RELEASE SOLID PREPARATION

TAKEDA PHARMACEUTIC




99 1/2008/501583 02/07/2008 20/10/2015

HOLOGRAPHIC FLEXIBLE TUBE LAMINATE FOR

PACKAGING AND METHOD OF MAKING

THE SAME

THE PAPER PRODUCTS

LIMITED, [IN]


100 1/2008/501719 24/07/2008 20/10/2015 LIGANDS THAT BIND IL-4 AND/OR IL-13

DOMANTIS LIMITED [UK]


OFFICES

101 1/2008/501844 13/08/2008 20/10/2015

LACTAM-CONTAINING COMPOUNDS AND

DERIVATIVES THEREOF AS FACTOR

XA INHIBITORS

BRISTOL-MYERS SQUIBB

COMPANY [US]


OFFICES

102 1/2008/501859 14/08/2008 20/10/2015 MODULATION OF BONE FORMATION WYETH [US]


OFFICES

103 1/2008/501884 19/08/2008 20/10/2015

PROCESS FOR PREPARING N-NUCLEIC ACID

DERIVATIVES AND INTERMEDIATES

THEREOF

NOVARTIS AG [CH]


104 1/2008/502128 22/09/2008 20/10/2015 HIGH-CALORIE NUTRITIONAL SUPPLEMENT

NESTEC S.A. [CH]


AND ONGSIAKO




105 1/2008/502150 24/09/2008 20/10/2015 TREATMENTS USING CITRULLINE

NESTEC S.A. [CH]


AND ONGSIAKO

106 1/2008/502190 29/09/2008 20/10/2015

LACTATE AND CALCIUM CONTAINING

PHARMACEUTICAL COMPOSITION AND

USES THEREOF

INNOGENE KALBIOTECH

PTE LTD, [SG] A.Q. ANCHETA

AND PARTNERS

107 1/2008/502224 03/10/2008 20/10/2015

NUTRITIONAL COMPOSITIONS FOR

PROMOTION OF BONE GROWTH AND

MAINTENANCE OF BONE HEALTH AND

METHODS REGARDING SAME

NESTEC S.A. [CH]


AND ONGSIAKO

108 1/2008/502240 03/10/2008 20/10/2015

POLYMER PRODUCT AND INTERFACIAL POLYMERISATION

PROCESS USING RAFT AGENT

THE UNIVERSITY OF SYDNEY [AU]

ROMULO MABANTA


DELOS ANGELES

109 1/2008/502251 07/10/2008 20/10/2015 OXADIAZOLIDINEDIONE COMPOUND

ASTELLAS PHARMA INC.

[JP] A.Q. ANCHETA

AND PARTNERS

110 1/2008/502328 17/10/2008 20/10/2015 FLOWABLE PARTICULATES

THE PROCTER AND GAMBLE

COMPANY [US]

SANTOS PILAPIL AND ASSOCIATES

111 1/2008/502381 27/10/2008 20/10/2015 HEPATITIS VIRUS

INFECTION BIOMARKERS

VERTEX PHARMACEUTIC

ALS INCORPORATED

[US]


OFFICES

112 1/2008/502424 03/11/2008 20/10/2015

GLUCOPYRANOSYL-SUBSTITUTED BENZONITRILE DERIVATIVES,

PHARMACEUTICAL COMPOSITIONS

CONTAINING SUCH COM

BOEHRINGER ENGELHEIM

INTERNATIONAL GMBH, [DE]


OFFICES

113 1/2008/502471 06/11/2008 20/10/2015 ANTICORROSIVE

COATING COMPOSITION

CHUGOKU MARINE PAINTS,

LTD., [JP]



114 1/2008/502487 07/11/2008 20/10/2015

COMBINATIONS COMPRISING

EPOTHILONES AND PHARMACEUTICAL

USES THEREOF

NOVARTIS AG [CH]


115 1/2008/502493 10/11/2008 20/10/2015 USE OF TETRAMIC ACID DERIVATIVES

FOR INSECT CONTROL

BAYER CROPSCIENCE

AG [DE]



116 1/2008/502651 02/12/2008 20/10/2015 WARFARIN DOSAGE PREDICTION

PHARMIGENE INC., [TW]





117 1/2008/502680 04/12/2008 20/10/2015

CLEANSING BAR COMPOSITIONS

COMPRISING A HIGH LEVEL OF WATER

THE PROCTER AND GAMBLE

COMPANY [US]


118 1/2008/502685 05/12/2008 20/10/2015 TRICYCLIC THROMBIN

RECEPTOR ANTAGONISTS


[US]


OFFICES

119 1/2008/502744 11/12/2008 20/10/2015

PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS OF A

SELECTIVE ANTAGONIST OF

EITHER CXCR2 OR BOTH CXCR1 AND

CXCR2 AND METHODS OF USING THE SAME

FOR TREATING INFLAMMATORY

DISORDERS

SCHERING CORPORATION

[US]


120 1/2009/000136 04/05/2009 20/10/2015

METHOD OF PRODUCING ECO-

FRIENDLY AEROGEL FROM RICE AND RICE

HULLS

CARDENAS III, FORTUNATO T

[PH]

CYNTHIA T. CARDENAS

121 1/2009/000153 22/05/2009 20/10/2015 LANA DE GLUTATHIONE ERIC DIAZ [PH]

122 1/2009/000250 29/07/2009 20/10/2015 OXIDATION STABILITY

USING NATURAL ANTIOXIDANTS


[US]


GATMAITAN

123 1/2009/000392 18/12/2009 20/10/2015

FUNGICIDAL COMBINATIONS

COMPRISING GLYOXALIC ACID

METHYL-O-METHYLOXIME DERIVATIVES

BAYER AKTIENGESELLS

CHAFT [DE] E.B. ASTUDILLO

AND ASSOCIATES

124 1/2009/500070 07/01/2009 20/10/2015

3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-

DIONES AS CXC-CHEMOKINE

RECEPTOR LIGANDS

PHARMACOPEIA , INC. [US] AND

SCHERING CORPORATION,

[US]


GATMAITAN

125 1/2009/500098 12/01/2009 20/10/2015

FUNGICIDE HYDROXIMOYL-

TETRAZOLE DERIVATIVES

BAYER CROPSCIENCE

S.A., [FR]


126 1/2009/500099 12/01/2009 20/10/2015 FUNGICIDE

HYDROXIMOYL-TETRAZOLE

DERIVATIVES

BAYER CROPSCIENCE

S.A., [FR]


127 1/2009/500126 15/01/2009 20/10/2015

NEW INDICATIONS FOR DIRECT THROMBIN INHIBITORS IN THE CARDIOVASCULAR

FIELD

BOEHRINGER INGELHEIM



OFFICES

128 1/2009/500128 15/01/2009 20/10/2015 INFLUENZA VACCINE GLAXOSMITHKLI

NE BIOLOGICALS





S.A., [BE] OFFICES

129 1/2009/500209 29/01/2009 20/10/2015

TERMINATING BROMINATION OF

STYRENIC POLYMER IN A BROMINATION

REACTION MIXTURE

ALBEMARLE CORPORATION,

[US]

ROMULO MABANTA


DELOS ANGELES

130 1/2009/500216 30/01/2009 20/10/2015

NOVEL AMINOPYRIDINE

DERIVATIVES HAVING AURORA A SELECTIVE

INHIBITORY ACTION

MSD K.K. [JP]

ROMULO MABANTA


ANGELES

131 1/2009/500256 06/02/2009 20/10/2015 INDOLE COMPOUNDS IRONWOOD

PHARMACEUTICALS, INC., [US]

AGCAOILI ASSOCIATES

132 1/2009/500265 09/02/2009 20/10/2015

ARYLAMINOARYL-ALKYL-SUBSTITUTED IMIDAZOLIDINE-2,4-

DIONES, PROCESSES FOR PREPARING

THEM, MEDICAMENTS COMPRISING THESE COMPOUNDS, AND

THEIR USE

SANOFI-AVENTIS, [FR]


133 1/2009/500339 20/02/2009 20/10/2015

TRANSDERMAL THERAPEUTIC SYSTEM

WITH HIGH RATE OF UTILIZATION OF

ACTIVE SUBSTANCE AND DOSING ACCURACY

LTS LOHMANN THERAPIE-

SYSTEME AG, [DE]


134 1/2009/500372 25/02/2009 20/10/2015 BEVERAGE CREAMER NESTEC S.A. [CH]


AND ONGSIAKO

135 1/2009/500407 03/03/2009 20/10/2015

METHOD OF OPTIMIZING THE TREATMENT OF PHILADELPHIA-

POSITIVE LEUKEMIA WITH ABL TYROSINE KINASE INHIBITORS

NOVARTIS AG, [CH]


136 1/2009/500425 06/03/2009 20/10/2015 PESTICIDAL HETEROCYCLES

FMC CORPORATION

[US]


AND ONGSIAKO

137 1/2009/500431 06/03/2009 20/10/2015

USE OF HPPD INHIBITORS IN THE

TREATMENT OF DEPRESSION AND/OR

WITHDRAWAL SYMPTOMS

ASSOCIATED WITH ADDICTIVE DRUGS

SYNGENTA LIMITED, [GB]

ROMULO MABANTA


DELOS ANGELES

138 1/2009/500434 06/03/2009 20/10/2015 COMPOUNDS AND METHODS FOR 18F LABELED AGENTS

BAYER SCHERING PHARMA

AKTIENGESELLSCHAFT, [DE]






139 1/2009/500438 09/03/2009 20/10/2015 NOVEL PHENYLACETIC ACID DERIVATIVE

FUJI YAKUHIN CO., LTD., [JP]


140 1/2009/500447 11/03/2009 20/10/2015 METHODS OF

PROVIDING LONG-TERM NUTRITION

NESTEC S.A., [CH]


AND ONGSIAKO

141 1/2009/500482 13/03/2009 20/10/2015

NOVEL BENZOFURAN TYPE DERIVATIVES, A

COMPOSITION COMPRISING THE

SAME FOR TREATING OR PREVENTING

COGNITIVE DYSFUNCTION AND THE USE THEREOF

DAEWONG PHARMACEUTIC

AL CO., LTD., [KR] AND

MEDIFRON DBT CO., LTD. [KR]


142 1/2009/500744 20/04/2009 20/10/2015 TREATED EXPANDED POLYSTERENE FOAM

LANXESS CORPORATION,

[US]


143 1/2009/500745 20/04/2009 20/10/2015 COMPOSITIONS OF CHK1 INHIBITORS

ICOS CORPORATION,

[US]

AGCAOILI ASSOCIATES

144 1/2009/500749 20/04/2009 20/10/2015 USE OF SULFONYLUREAS

BAYER CROPSCIENCE

AG, [DE]

CESAR C. CRUZ & PARTNERS LAW

OFFICES

145 1/2009/500809 27/04/2009 20/10/2015 GOLD ALLOY WIRE FOR BALL BONDING

TANAKA DENSHI KOGYO K.K.,

[JP]



146 1/2009/500812 27/04/2009 20/10/2015

POLYSTYRENE-MALEIC ANHYDRIDE/MAGNESIU

M HYDROXIDE COMPOSITE

PARTICLES AND METHODS FOR

PREPARING THE SAME

YAZAKI CORPORATION,

[JP] AND NAGASAKI

UNIVERSITY, NATIONAL

UNIVERSITY CORPORATION,

[JP]


AQUINO (SAFA LAW)

147 1/2009/500842 30/04/2009 20/10/2015 ENHANCED AMINO ACID FORMULATIONS

VALENT BIOSCIENCES

CORPORATION, [US]


GATMAITAN

148 1/2009/500869 05/05/2009 20/10/2015 A SOAP BAR

STRUCTURED USING TRANS FATTY ACID

UNILEVER N.V., [NL]

OSCAR M. MANAHAN

149 1/2009/500875 06/05/2009 20/10/2015

PRODUCTION OF NOVEL PRECISION

CUSTOMIZED CONTROL RELEASE

FERTILIZERS

BIJAM BIOSCIENCES

PRIVATE LIMITED, [IN]

MUTIA TRINIDAD & PANTANOSAS

150 1/2009/500880 06/05/2009 20/10/2015 TOBACCO SMOKE

FILTER AND METHODS OF MAKING THE SAME

BRITISH AMERICAN TOBACCO

(INVESTMENTS) LIMITED, [UK]



151 1/2009/500948 15/05/2009 20/10/2015

STRUCTURALLY MODIFIED LIGNITE WITH OR WITHOUT

EXTRACTION OF FUNCTIONALLY

BIJAM BIOSCIENCES

PRIVATE LIMITED [IN]

MUTIA TRINIDAD & PANTANOSAS




ENHANCED ORGANIC MOLECULES

152 1/2009/501079 29/05/2009 20/10/2015 ABETA ANTIBODY

PARENTERAL FORMULATION

F.HOFFMANN-LA ROCHE AG,

[CH] E.B. ASTUDILLO

AND ASSOCIATES

153 1/2009/501089 02/06/2009 20/10/2015 METARHIZIUM

ANISOPLIAE VAR. DCJHYIUM AND USES

THEREOF

GREEN LIFE LABORATORY LIMITED, [CN]

DEL ROSARIO & DEL ROSARIO

154 1/2009/501099 03/06/2009 20/10/2015

GLUCOCORTICOID MIMETICS, METHODS

OF MAKING THEM, PHARMACEUTICAL

COMPOSITIONS, AND USES THEREOF




OFFICES

155 1/2009/501113 04/06/2009 20/10/2015

METHOD FOR DETERMINING THE

STABILITY OF ORGANIC

METHYLENEAMINES IN THE PRESENCE OF SEMICARBAZIDE-SENSITIVE AMINE

OXIDASE

SANOFI-AVENTIS, [FR] SANKAR, SABITA

156 1/2009/501118 04/06/2009 20/10/2015 CHEMICAL COMPOUNDS

SYNGENTA PARTICIPATIONS

AG [CH]


157 1/2009/501124 05/06/2009 20/10/2015 MONOCLONAL

ANTIBODIES AGAINST ANGPTL3

LEXICON PHARMACEUTICALS, INC., [US]


GATMAITAN

158 1/2009/501131 05/06/2009 20/10/2015 ANIMAL FEED COMPOSITIONS

U.S. BORAX INC., [US]


BULILAN LAW OFFICES

159 1/2009/501136 08/06/2009 20/10/2015 NOVEL COMPOSITIONS AND USES THEREOF

TIMA FOUNDATION,

[LI]


160 1/2009/501175 11/06/2009 20/10/2015

DR6 ANTAGONISTS AND USES THEREOF IN

TREATING NEUROLOGICAL

DISORDERS

GENENTECH, INC., [US]


161 1/2009/501207 16/06/2009 20/10/2015 A PLANT ROOT

SYSTEM IMPROVING COMPOSITION

MALAYSIAN AGRI HI-TECH

SDN BHD, [MY] HECHANOVA AND

CO. INC.

162 1/2009/501254 19/06/2009 20/10/2015 PHARMACEUTICAL PREPARATION FOR

THE ALLEVIATION OF ENDOMETRIOSIS





163 1/2009/501260 22/06/2009 20/10/2015 AGENTS FOR

PROMOTING IGA PRODUCTION

CALPIS CO.,LTD, [JP]


OFFICES

164 1/2009/501262 22/06/2009 20/10/2015

USE OF LONG-ACTING GLP-1 RECEPTOR

AGONISTS TO IMPROVE INSULIN

CENTOCOR ORTHO BIOTECH

INC., [US]

ROMULO MABANTA





SENSITIVITY AND LIPID PROFILES

DELOS ANGELES

165 1/2009/501415 16/07/2009 20/10/2015

METHODS FOR PREVENTING

GLUCONOYLATION OF PROTEINS

SMITHKLINE BEECHAM

CORPORATION, [US]


166 1/2009/501426 21/07/2009 20/10/2015 CANCEROUS DISEASE

MODIFYING ANTIBODIES

F. HOFFMANN-LA ROCHE AG,

[CH]


GATMAITAN

167 1/2009/501480 31/07/2009 20/10/2015

USE OF SEMAPHORIN 6A FOR PROMOTING MYELINATION AND

OLIGODENDROCYTE DIFFERENTIATION

BIOGEN IDEC MA INC., [US];

CENTRE NATIONAL DE RECHERCHE

SCIENTIFIQUE, [FR] AND

UNIVERSITY PIERRE AND

MARIE CURIE, [FR]


OFFICES

168 1/2009/501497 04/08/2009 20/10/2015 NOVEL PHOSPHODI ESTERASE INHIBITORS

LEO PHARMA A/S, [DK]


169 1/2009/501500 04/08/2009 20/10/2015 ANTI-ROBO4

ANTIBODIES AND USES THEREFOR



170 1/2009/501542 11/08/2009 20/10/2015 CANCER TREATMENT METHOD

SMITHKLINE BEECHAM

CORPORATION, [US]


171 1/2009/501595 20/08/2009 20/10/2015 HAIR TREATMENT COMPOSITIONS

CONTAINING SOPHORA ALKALOIDS

UNILEVER N.V., [NL]

OSCAR M. MANAHAN

172 1/2009/501645 27/08/2009 20/10/2015

ANTAGONIST OX40 ANTIBODIES AND THEIR USE IN THE

TREATMENT OF INFLAMMATORY AND

AUTOIMMUNE DISEASES



173 1/2009/501647 27/08/2009 20/10/2015

INHIBITORS OF SERINE PROTEASES FOR THE TREATMENT OF HCV

INFECTIONS

VERTEX PHARMACEUTIC

ALS INCORPORATED,

[US]

AGCAOILI ASSOCIATES

174 1/2009/501665 28/08/2009 20/10/2015 DIAMINOPYRIMIDINES AS FUNGICIDES

BAYER CROPSCIENCE

AG, [DE]



175 1/2009/501673 01/09/2009 15/10/2015

SUBSTITUTED DIHYDRO AND TETRAHYDRO

OXAZOLOPYRIMIDINONES, PREPARATION AND

USE THEREOF


CESAR C. CRUZ & PARTNERS LAW OFFICES

176 1/2009/501834 25/09/2009 20/10/2015 SOLID PHARMACEUTICAL

TAKEDA PHARMACEUTIC

ORTEGA DEL CASTILLO




COMPOSITION COMPRISING A

BENZIMIDAZOLE-7-CARBOXYLATE

DERIVATIVE AND A PH CONTROL AGENT

AL COMPANY LIMITED, [JP]

BACORRO ODULIO CALMA

AND CARBONELL

177 1/2009/501848 29/09/2009 20/10/2015


INDUCING APOPTOSIS BY STIMULATING ER

STRESS

UNIVERSITY OF SOUTHERN CALIFORNIA

USC STEVENS, [US]


178 1/2009/501935 09/10/2009 20/10/2015 BIOMARKERS FOR MULTIPLE SCLEROSIS

APITOPE INTERNATIONAL

NV, [BE]


179 1/2009/501938 09/10/2009 20/10/2015


TREATING SLEEP-RELATED BREATHING

DISORDERS

SEPRACOR, INC., [US]



180 1/2009/501965 14/10/2009 20/10/2015 PATTERNED WRAPPER PAPER WITH AN ANTI-

WRINKLING AGENT

PHILIP MORRIS PRODUCTS S.A.,

[CH]


OFFICES

181 1/2009/501976 14/10/2009 20/10/2015

SELECTIVE INSECTICIDES BASED

ON HALOALKYLNICOTINIC

ACID DERIVATIVES, ANTHRANILIC ACID

DIAMIDES, OR PHTHALIC ACID DIAMIDES AND

SAFENERS

BAYER CROPSCIENCE

AG, [DE]



182 1/2009/502006 20/10/2009 20/10/2015 OIL-IN-WATER

EMULSION INFLUENZA VACCINE

GLAXOSMITHKLINE

BIOLOGICALS S.A., [BE]


OFFICES

183 1/2009/502031 23/10/2009 20/10/2015

NOVEL ANTIBODY MOLECULES AND NUCLEIC ACIDS

BINDING TO FUNGAL STRESS PROTEIN

HSP90

NOVARTIS AG, [CH]


184 1/2009/502042 27/10/2009 20/10/2015

PROBIOTICS IN A PRE-AND/OR POST

SURGICAL ENVIRONMENT

NESTEC S.A., [CH]


AND ONGSIAKO

185 1/2009/502094 04/11/2009 20/10/2015

9-(PYRAZOL-3-YL)-9H-PURINE-2-AMINE AND 3-(PYRAZOL-3-YL) -3H-

IMIDAZO[4,5-B] PYRIDIN-5-AMINE

DERIVATIVES AND THEIR USE FOR THE

TREATMENT OF CANCER

ASTRAZENECA AB, [SE]


186 1/2009/502107 05/11/2009 20/10/2015 PROCESS FOR THE PREPARATION OF

NOVARTIS AG, [CH]





TETRAZOLE DERIVATIVES FROM

ORGANO BORON AND ORGANO ALUMINUM

AZIDES

187 1/2009/502151 12/11/2009 20/10/2015 FUNGICIDES PHENYL-PYRIMDINYL-AMINO

DERIVATIVES

BAYER CROPSCIENCE

SA, [FR]


188 1/2009/502178 16/11/2009 20/10/2015 TREATMENT AND PREVENTION OF

INFLUENZA

COMMNWEALTH SCIENTIFIC AND

INDUSTRIAL RESEARCH

ORGANIZATION, [AU] AND MAT

MALTA ADVANCED

TECHNOLOGIES LIMITED, [MT]


GATMAITAN

189 1/2009/502199 17/11/2009 20/10/2015 NOVEL OIL-BASED

ADJUVANT COMPOSITION

BAYER CROPSCIENCE




190 1/2009/502211 20/11/2009 20/10/2015

ANTIVIRAL DRUGS FOR TREATMENT OR PREVENTION OF

DENGUE INFECTION

SIGA TECHNOLOGIES,

INC., [US]


191 1/2009/502324 04/12/2009 20/10/2015 POLYPEPTIDES,

ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS

DOMANTIS LIMITED, [UK]


OFFICES

192 1/2009/502371 10/12/2009 20/10/2015

TREATMENT OF DISEASES AND

DISORDERS USING SELF-RENEWING

COLONY FORMING CELLS CULTURED AND

EXPANDED IN VITRO

GARNET BIOTHERAPEUTI

CS INC., [US]


OFFICES

193 1/2009/502441 17/12/2009 20/10/2015

PIRENZIPINE AND DERIVATIVES

THEREOF AS ANTI-AMYLOID AGENTS

AC IMMUNE S.A., [CH] AND

PROTEOSYS AG, [DE]


194 1/2009/502443 16/12/2009 20/10/2015

METHODS AND COMPOSITIONS FOR TREATING ALLERGIC

DISEASES

IRM LLC, [BM] E.B. ASTUDILLO AND ASSOCIATES

195 1/2009/502456 17/12/2009 20/10/2015

SPECIFIC THERAPY AND MEDICAMENT USING INTEGRIN

LIGANDS FOR TREATING CANCER

MERCK PATENT GMBH, [DE]


196 1/2010/000196 05/07/2010 20/10/2015

A METHOD OF USING PLANT OILS AS AN

ENERGY SUPPLEMENT AND ANTI-RADIATION

JOHNNY N. SY [PH]

197 1/2010/000201 08/07/2010 20/10/2015 GLASS SUBSTRATE FOR INFORMATION

RECORDING MEDIUM

ASAHI GLASS COMPANY,

LIMITED [JP]





AND METHOD FOR MANUFACTURING THE SAME, AND MAGNETIC RECORDING MEDIUM

198 1/2010/000230 02/08/2010 20/10/2015 METHOD FOR MAKING

BETEL NUT FLAVOR CHEWING GUM

LIU, YEN-HSUN [TW]

NICOLAS & DE VEGA LAW OFFICES

199 1/2010/000374 17/11/2010 20/10/2015 METHOD FOR

MANUFACTURING GLASS SUBSTRATE

FOR MAGNETIC DISK

ASAHI GLASS COMPANY, LTD.

[JP] E.B. ASTUDILLO

AND ASSOCIATES

200 1/2010/000388 07/12/2010 20/10/2015

METHOD FOR MANUFACTURING

GLASS SUBSTRATE FOR DATA STORAGE MEDIUM AND GLASS

SUBSTRATE


LIMITED [JP]


201 1/2010/000410 17/12/2010 20/10/2015

METHOD FOR MANUFACTURING

GLASS SUBSTRATE FOR DATA STORAGE MEDIUM AND GLASS

SUBSTRATE

ASAHI GLASS COMPANY

LIMITED [JP] E.B. ASTUDILLO

AND ASSOCIATES

202 1/2010/500015 04/01/2010 20/10/2015 CHEMICAL COMPOUNDS




OFFICES

203 1/2010/500025 04/01/2010 20/10/2015 STEREOISOMERS OF

TRICYCLODECAN-9-YL-XANTHOGENATE

LUMAVITA AG, [CH]



204 1/2010/500069 11/01/2010 20/10/2015 FLORFENICOL

PRODRUG HAVING IMPROVED WATER

SOLUBILITY

SCHERING-PLOUGH LTD.

[CH]


AND ONGSIAKO

205 1/2010/500130 19/01/2010 20/10/2015

A RECOMBINANT KOI HERPESVIRUS (KHV)

OR CYRPINID HERPESVIRUS 3 (CYHV-3) AND A

VACCINE FOR THE PREVENTION OF A

DISEASE CAUSED BY KHV/CYHV-3 IN

CYPRINUS CARPIO OR CARPIO OR CYPRINUS

CARPIO KOI

UNIVERSITE DE LIEGE, [BE]


206 1/2010/500131 19/01/2010 20/10/2015 NOVEL HERBICIDES SYNGENTA LIMITED, [GB]


207 1/2010/500132 19/01/2010 20/10/2015 NOVEL HERBICIDES SYNGENTA LIMITED, [GB]


208 1/2010/500159 21/01/2010 20/10/2015 DUAL MODULATORS OF 5-HT2A AND D3

RECEPTORS

F. HOFFMANN -LA ROCHE AG,

[CH]


GATMAITAN

209 1/2010/500176 22/01/2010 20/10/2015 ANTIMICROBIAL

PEPTIDE, COMPOSITIONS, AND

REVANCE THERAPEUTICS,

INC., [US]


GATMAITAN




METHODS OF USE

210 1/2010/500186 25/01/2010 20/10/2015

POLYNUCLEOTIDES, POLYPEPTIDES

ENCODED THEREBY, AND METHODS OF USING SAME FOR

INCREASING ABIOTIC STRESS TOLERANCE

AND/OR BIOMASS AND/OR YIELD IN

PLANTS EXPRESSING SAME

EVOGENE LTD., [IL]


OFFICES

211 1/2010/500231 28/01/2010 15/10/2015

ANTI-MITOTIC AGENT AND AURORA KINASE

INHIBITOR COMBINATION AS

ANTI-CANCER TREATMENT

SCHERING CORPORATION,

[US]


GATMAITAN

212 1/2010/500263 02/02/2010 20/10/2015

USE OF HESPERIDIN OR OF A DERIVATIVE THEREOF FOR THE

PREVENTION AND/OR TREATMENT OF

SLACKENED SKIN

L`OREAL, [FR] AND NESTEC SA,

[CH]

ROMULO MABANTA


DELOS ANGELES

213 1/2010/500265 02/02/2010 20/10/2015

USE OF URATE OXIDASE FOR THE

TREATMENT OR PROPHYLAXIS OF DISORDERS OR

INDERECT SEQUELAE OF THE HEART

CAUSED BY ISCHEMIC OR REPERFUSION

EVENTS



214 1/2010/500278 04/02/2010 20/10/2015 IMMUNOGENIC

STREPTOCOCCUS PROTEINS

BOEHRINGER INGELHEIM VETMEDICA GMBH, [DE]


OFFICES

215 1/2010/500305 08/02/2010 20/10/2015 PEPTIDE SEQUENCES AND COMPOSITIONS

PEPTCELL LIMITED, [GB]


AND ONGSIAKO

216 1/2010/500338 11/02/2010 20/10/2015 PYRAZOLE

COMPOUNDS FOR CONTROLLING

INVERTEBRATE PESTS

BASF SE, [DE] E.B. ASTUDILLO AND ASSOCIATES

217 1/2010/500351 12/02/2010 20/10/2015

RNA SEQUENCE MOTIFS IN THE

CONTEXT OF DEFINED INTERNUCLEOTIDE

LINKAGES INDUCING SPECIFIC IMMUNE

MODULATORY PROFILES

COLEY PHARMACEUTICAL GMBH, [DE]


GATMAITAN

218 1/2010/500370 16/02/2010 20/10/2015

PHARMACEUTICAL COMPOSITION

COMPRISING A SGLT2 INHIBITOR IN


INTERNATIONAL GMBH [DE]


OFFICES




COMBINATION WITH A DPP-IV INHIBITOR

219 1/2010/500372 16/02/2010 20/10/2015 SMOKING ARTICLE

WITH MODIFIED SMOKE DELIVERY


(INVESTMENTS) LIMITED, [UK]



220 1/2010/500426 23/02/2010 20/10/2015 METHODS AND

COMPOSITIONS FOR DIAGNOSING DISEASE

INTREXON CORPORATION,

[US]


OFFICES

221 1/2010/500435 24/02/2010 20/10/2015

FLOURINE - CONTAINING

ORGANOSULFUR COMPOUND AND

PESTICIDAL COMPOSITION

COMPRISING THE SAME

SUMITOMO CHEMICAL COMPANY

LIMITED, [JP]

SYCIP SALAZAR HERNANDEZ &

GATMAITAN

222 1/2010/500444 24/02/2010 20/10/2015

HALOGEN ALKOXY SPIROCYCLIC

TETRAMIC AND TETRONIC ACID

DERIVATIVES

BAYER CROPSCIENCE

AKTIENGESELLSCHAFT [DE]



223 1/2010/500446 25/02/2010 20/10/2015 A METHOD OF TREATING FABRIC

UNILEVER N.V., [NL]

OSCAR M. MANAHAN

224 1/2010/500447 25/02/2010 20/10/2015

STABLE LIQUID CLEANSING

COMPOSITIONS CONTAINING FATTY ACYL ISETHIONATE

SURFACTANT

UNILEVER N.V., [NL]

OSCAR M. MANAHAN

225 1/2010/500468 01/03/2010 20/10/2015 WOLFBERRIES AND INFLAMMATION

NESTEC S.A., [CH]


AND ONGSIAKO

226 1/2010/500469 01/03/2010 20/10/2015 CATECHOLAMINE DERIVATIVES AND

PRODRUGS THEREOF

H. LUNDBECK A/S, [DK]


227 1/2010/500476 02/03/2010 20/10/2015

COMPOSITIONS AND METHODS FOR

TREATING IMMUNOLOGICAL AND

INFLAMMATORY DISEASES AND

DISORDERS

LEXICON PHARMACEUTIC

ALS, INC. [US]


228 1/2010/500481 02/03/2010 20/10/2015

METHODS AND DEVICE FOR PRODUCING HYDROGEN FROM

BIOMASS

SIDKAR GREEN TECHNOLOGIES

LLP [IN]



229 1/2010/500496 04/03/2010 20/10/2015

A METHOD FOR PREPARING PROTEIN CONCENTRATE FROM

RICE BRAN

CJ CHIELJEDANG

CORPORATION, [KR]


230 1/2010/500497 04/03/2010 20/10/2015

PIPERIDINYLAMINO-THIENO[2,3-D] PYRIMIDINE

COMPOUNDS FOR

TROVIS PHARMACEUTIC

ALS LLC [US]





TREATING FIBROSIS

231 1/2010/500498 04/03/2010 20/10/2015

METHOD FOR PRODUCING JUICE

HAVING PRE-SELECTED

PROPERTIES AND CHARACTERISTICS

TROPICANA PRODUCTS, INC., [US]

CRUZ MARCELO TENEFRANCIA

232 1/2010/500514 09/03/2010 20/10/2015

(CARBOXYLALKYLENE-PHENYL)-PHENYL-

OXALAMIDES, METHOD FOR THE PRODUCTION THEREOF, AND USE OF

SAME AS A MEDICAMENT

SANOFI-AVENTIS [FR]


233 1/2010/500537 11/03/2010 20/10/2015 TREATMENT OF

VASOMOTOR SYMPTOMS




OFFICES

234 1/2010/500549 12/03/2010 20/10/2015

INSECTICIDAL CARBAMATES

EXHIBITING SPECIES-SELECTIVE INHIBITION

OF ACETYLCHOLINESTER

ASE (ACHE)

VIRGINIA TECH INTELLECTUAL PROPERTIES,

INC., [US]

ESCAÑO SARMIENTO AND

PARTNERS

235 1/2010/500550 12/03/2010 20/10/2015

IMPROVEMENTS RELATING TO FABRIC

TREATMENT COMPOSITIONS

UNILEVER N.V., [NL]

OSCAR M. MANAHAN

236 1/2010/500552 12/03/2010 20/10/2015 HUMAN GM-CSF

ANTIGEN BINDING PROTEINS

AMGEN, INC., [US]


237 1/2010/500592 18/03/2010 20/10/2015

COMPOSITIONS COMPRISING

SPHINGOSINE 1 PHOSPHATE (S1P)

RECEPTOR MODULATORS

NOVARTIS AG, [CH]


238 1/2010/500665 26/03/2010 20/10/2015

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY

IRM LLC, [BM] E.B. ASTUDILLO AND ASSOCIATES

239 1/2010/500676 29/03/2010 20/10/2015

SALTS OF CGRP ANTAGONIST, METHOD FOR PRODUCING THE

SAME AND USE THEREOF AS DRUGS




OFFICES

240 1/2010/500704 30/03/2010 20/10/2015 RODENTICIDAL MIXTURE BASF SE, [DE] E.B. ASTUDILLO

AND ASSOCIATES

241 1/2010/500774 12/04/2010 20/10/2015 RAPID ACTING

INJECTABLE INSULIN COMPOSITIONS

BIODEL, INC. [US]

A.Q. ANCHETA & PARTNERS

242 1/2010/500789 13/04/2010 20/10/2015

COMPOSITIONS FOR ELICITING AN IMMUNE RESPONSE AGAINST

MYCOBACTERIUM AVIUM SUBSPECIES

CORNELL UNIVERSITY [US]

ROMULO MABANTA


DELOS ANGELES




PARATUBERCULOSIS

243 1/2010/500805 14/04/2010 20/10/2015

FORMULATION TO IMPROVE

GASTROINTESTINAL FUNCTION

UNIVERSITY OF FLORIDA

RESEARCH FOUNDATION,

INC., [US]

JDF LAW OFFICE

244 1/2010/500843 16/04/2010 20/10/2015 CRYSTALLINE

INDAZOLE - DERIVED CHEMOTHERAPEUTIC

ABBVIE BAHAMAS LTD.

[BS]


GATMAITAN

245 1/2010/500893 23/04/2010 20/10/2015

METHOD FOR PRODUCING

ENCAPSULATED SODIUM

PERCARBONATE PARTICLES

EVONIK DEGUSSA

GMBH, [DE]


246 1/2010/500931 28/04/2010 20/10/2015 TREATMENT OF ORAL

PHARYNGEAL DYSPHAGIA

NESTEC S.A., [CH]


OFFICES

247 1/2010/500945 28/04/2010 20/10/2015

CONTINUOUS METHOD FOR THE

HETEROGENICALLY CATALYZED

ESTERIFICATION OF FATTY ACIDS

BAYER INTELLECTUAL

PROPERTY GMBH [DE]



248 1/2010/500947 28/04/2010 20/10/2015

PYRROLO [1,2-C] IMIDAZOLE

DERIVATIVES FOR USE IN THE PROPHYLAXIS OR TREATMENT OF CANCER WHICH IS REFRACTORY TO KNOWN CANCER

THERAPIES

TAKEDA PHARMACEUTIC


ORTEGA, BACORRO,

ODULIO, CALMA & CARBONELL

249 1/2010/500984 30/04/2010 20/10/2015

PLANTS WITH ALTERED ROOT ARCHITECTURE,

RELATED CONSTRUCTS AND

METHODS INVOLVING GENES ENCODING

EXOSTOSIN FAMILY POLYPEPTIDES AND

HOMOLOGS THEREOF

E.I. DU PONT DE NEMOURS AND COMPANY [US] AND PIONEER

HI-BRED INTERNATIONAL,

INC. [US]



250 1/2010/501005 05/05/2010 20/10/2015




LEUCINE RICH REPEAT KINASE (LLRK)

POLYPEPTIDES AND HOMOLOGS THEREOF

E.I. DUPONT DE NEMOURS AND COMPANY [US] AND PIONEER


INC. [US]


ODULIO CALMA & CARBONELL

251 1/2010/501011 06/05/2010 20/10/2015 HYPOALLERGENIC CEREAL PROTEIN AND

NESTEC S.A., [CH]





USES THEREOF AND ONGSIAKO

252 1/2010/501063 12/05/2010 20/10/2015

METHOD FOR PRODUCING A

THICKENER DISPERSION

BASF SE, [DE] E.B. ASTUDILLO AND ASSOCIATES

253 1/2010/501065 13/05/2010 20/10/2015 FISH FOOD CAPSULE AYANDA GMBH & CO. KG, [DE]


254 1/2010/501079 13/05/2010 20/10/2015 ORAL DISPERSABLE TABLET





255 1/2010/501096 14/05/2010 20/10/2015 FROZEN

CONFECTIONERY PRODUCT

NESTEC S.A., [CH]


AND ONGSIAKO

256 1/2010/501098 14/05/2010 20/10/2015

COMPOSITION DERIVED FROM A

MEAT SOURCE AND PROCESSES FOR

MAKING AND USING COMPOSITION

BUMBLE BEE FOODS, LLC,

[US]

AGCAOILI ASSOCIATES

257 1/2010/501099 14/05/2010 20/10/2015

THERAPEUTIC USES OF COMPOUNDS

HAVING AFFINITY TO THE SEROTONIN TRANSPORTER,

SEROTONIN RECEPTORS AND NORADRENALIN TRANSPORTER

H. LUNDBECK A/S, [DK] AND

TAKEDA PHARMACEUTIC

ALS NORTH AMERICA, INC.,

[US]


258 1/2010/501107 14/05/2010 20/10/2015 ANTIVIRAL

NUCLEOSIDE COMPOUNDS

LIGAND PHARMACEUTICALS, INC., [US]


GATMAITAN

259 1/2010/501111 14/05/2010 20/10/2015 BIVALENT, BISPECIFIC ANTIBODIES

F. HOFFMANN -LA ROCHE AG

[CH]


GATMAITAN

260 1/2010/501126 14/05/2010 20/10/2015

METHOD FOR TREATING OBESITY

AND OBESITY RELATED DISEASES

AND DISORDERS

AMYLIN PHARMACEUTICALS, INC., [US]



261 1/2010/501142 18/05/2010 20/10/2015

PYRAZOLYL DERIVATIVES IN THE

FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL

REGRESSIONS

AVENTIS-PHARMA S.A.,

[FR]


AQUINO (SAFA LAW)

262 1/2010/501171 20/05/2010 20/10/2015

BLUETONGUE VIRUS VACCINE AND IMMUNOGENIC

COMPOSITIONS, METHODS OF USE AND

METHODS OF PRODUCING SAME

WYETH FARMA, S.A., [ES]


263 1/2010/501188 25/05/2010 20/10/2015 AMINO ACID SEQUENCES

ABLYNX N.V., [BE]





DIRECTED AGAINST HETERODIMERIC

CYTOKINES AND/OR THEIR RECEPTORS AND POLYPEPTIDES

COMPRISING THE SAME


264 1/2010/501200 26/05/2010 20/10/2015

USE OF HUMAN ANTIBODY CAPABLE OF NEUTRALIZING HEPATITIS B VIRUS

FOR THE PREVENTION OR TREATMENT OF HEPATITIS B VIRUS

INFECTION

GREEN CROSS CORPORATION,

[KR]

ROMULO MABANTA


DELOS ANGELES

265 1/2010/501215 26/05/2010 20/10/2015

IMPLANTABLE DRUG DELIVERY DEVICE AND

METHODS FOR TREATMENT OF THE

BLADDER AND OTHER BODY VESICLES OR

LUMENS

MASSACHUSETTS INSTITUTE OF TECHNOLOGY,

[US]

ROMULO MABANTA


DELOS ANGELES

266 1/2010/501255 31/05/2010 20/10/2015

A METHOD FOR BUILDING OF HARD

WATER AND A BUILDER SYSTEM FOR

A DETERGENT COMPOSITION

UNILEVER N.V., [NL]

OSCAR M. MANAHAN

267 1/2010/501272 03/06/2010 20/10/2015 A PRODUCT TO BOOST PHOTOSYNTHESIS

SREE RAMCIDES CHEMICALS PVD

LTD, [IN] NORIEVA D. DE

VEGA

268 1/2010/501292 04/06/2010 20/10/2015

MEDICAL USE OF 3-(2,2,2-

TRIMETHYLHYDRAZINIUM PROPIONATE

HYDROGEN FUMARATE AND

DIHYDROGEN PHOSPHATE

GRINDEKS, [LV] A.Q. ANCHETA AND PARTNERS

269 1/2010/501294 04/06/2010 20/10/2015 VACCINE

GLAXOSMITHKLINE

BIOLOGICALS S.A., [BE]


OFFICES

270 1/2010/501305 04/06/2010 20/10/2015 INHIBITION OF

SCARRING USING TGF-BETA 3

RENOVO LIMITED, [GB]


271 1/2010/501306 04/06/2010 20/10/2015

FUSED PYRIDINE, PYRIMIDINE AND

TRIAZINE COMPOUNDS AS CELL CYCLE

INHIBITORS

AMGEN INC., [US]


272 1/2010/501315 07/06/2010 20/10/2015

PHENYLEPHRINE PHARMACEUTICAL

FORMULATIONS AND COMPOSITIONS FOR

TRANSMUCOSAL ABSORPTION

SCHERING-PLOUGH

HEALTH CARE PRODUCTS, INC,

[US]


GATMAITAN




273 1/2010/501319 08/06/2010 20/10/2015 OCTAHYDROQUINOLIZI

NES FOR ANTIDIABETIC TREATMENT

55PHARMA DRUG

DISCOVERY & DEVELOPMENT

AG [AT]

ORTEGA, BACORRO,


274 1/2010/501320 09/06/2010 20/10/2015 BIVALENT, BISPECIFIC ANTIBODIES

F. HOFFMANN-LA ROCHE AG,

[CH]


GATMAITAN

275 1/2010/501326 09/06/2010 20/10/2015 ANTIGEN BINDING PROTEINS

GLAXO GROUP LIMITED [GB]


OFFICES

276 1/2010/501370 16/06/2010 20/10/2015

SUBSTITUTED 4-(3-[6-AMINO-9-(3,4-DIHYDROXY-

TETRAHYDRO-FURAN-2-YL)-9H-PURIN-2-YL]-

PROP-2-YNYL)-PIPERIDINE-1-

CARBOXYLIC ACID ESTERS AS A24R

AGONISTS

TROVIS PHARMACEUTIC

ALS LLC [US] SANKAR, SABITA

277 1/2010/501371 16/06/2010 20/10/2015 4-IMIDAZOLIDINONES AS KV1.5 POTASSIUM CHANNEL INHIBITORS

WYETH LLC [US] E.B. ASTUDILLO AND ASSOCIATES

278 1/2010/501373 16/06/2010 20/10/2015 INSECTICIDAL COMPOUNDS


AG, [CH]


279 1/2010/501393 17/06/2010 20/10/2015

1, 2, 4 - OXADIAZOLE COMPOUNDS FOR THE

TREATMENT OF AUTOIMMUNE

DISEASES

GLAXO GROUP LIMITED, [GB]


280 1/2010/501402 18/06/2010 20/10/2015 INJECTION

COMPRISING DOCETAXEL AND ITS

PREPARATION

TTY BIOPHARM COMPANY,

LIMITED [CN]


281 1/2010/501403 18/06/2010 20/10/2015 VACCINE GLAXOSMITHKLI

NE BIOLOGICALS

S.A [BE]


OFFICES

282 1/2010/501456 23/06/2010 20/10/2015 NANODISPERSION

SUN PHARMA ADVANCED RESEARCH COMPANY

LIMITED [IN]

FIRST IP CONSULTANCY AND TECHNICAL

SERVICES

283 1/2010/501457 23/06/2010 20/10/2015 VACCINES FOR MALARIA

GLAXOSMITHKLINE

BIOLOGICALS S.A. [BE]


OFFICES

284 1/2010/501475 25/06/2010 20/10/2015

ANTIBODY-CONTAINING

FORMULATION FOR THE USE FOR

TREATING CARDIOVASCULAR

DISEASES ASSOCIATED WITH

BIOINVENT INTERNATIONAL

AB [SE]

OSCAR M. MANAHAN, ESQ.




ATHEROSCLEROSIS

285 1/2010/501490 28/06/2010 20/10/2015

COMPOSITIONS CONTAINING SESAMIN-CLASS COMPOUNDS(S)

AND QUERCETIN GLYCOSIDE(S)

SUNTORY HOLDINGS

LIMITED, [JP]

286 1/2010/501525 02/07/2010 20/10/2015 ANTIBODY TARGETING THROUGH A MODULAR RECOGNITION DOMAIN

THE SCRIPPS RESEARCH

INSTITUTE [US]



287 1/2010/501552 08/07/2010 20/10/2015 CAPSULE FORMULATION

TAKEDA PHARMACEUTIC

AL COMPANY LIMITED, [JP]

288 1/2010/501654 22/07/2010 20/10/2015

HUMANIZED ANTIBODIES SPECIFIC FOR VON WILLEBRAND

FACTOR

GLENMARK PHARMACEUTIC

ALS S.A. [CH]

ORTEGA DEL CASTILLO

BACORRO ODUIO CALMA &

CARBONELL

289 1/2010/501667 23/07/2010 20/10/2015

SALT FORMS OF A 6-FLUORO-1,2-DIHYDRO-

2-OXO-3H-INDOL-3-YLIDENE DERIVATIVE, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL

COMPOSITIONS CONTAINING SAME



CASTILLO LAMAN TAN

PANTALEON & SAN JOSE

290 1/2010/501676 23/07/2010 20/10/2015

AZABICYCLIC CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND

THERAPEUTIC USE THEREOF

SANOFI-AVENTIS [FR]

SALUDO FERNANDEZ

AQUINO & TALEON

291 1/2010/501699 27/07/2010 20/10/2015 METHOD FOR

PREPARING POROUS COLLAGEN MATRICES

NATIONAL CHENG KUNG UNIVERSITY

[TW]

NICOLAS & DE VEGA LAW OFFICES

292 1/2010/501702 27/07/2010 20/10/2015

TETRAHYDROQUINOXALINE UREA

DERIVATIVES, THEIR PREPARATION AND

THEIR THERAPEUTIC APPLICATION

SANOFI-AVENTIS [FR]


AQUINO (SAFA LAW)

293 1/2010/501706 27/07/2010 20/10/2015 INHIBITORS OF THE

CHEMOKINE RECEPTOR CXCR3

SANOFI-AVENTIS [FR]


294 1/2010/501728 29/07/2010 20/10/2015

MODIFIED RELEASE FORMULATIONS OF

HMG COA REDUCTASE INHIBITORS

LUPIN LIMITED [IN]

FIRST IP CONSULTANCY AND TECHNICAL

SERVICES

295 1/2010/501760 02/08/2010 20/10/2015 USE OF RANOLAZINE FOR TREATING PAIN

GILEAD SCIENCES, INC.

[US]


GATMAITAN




296 1/2010/501802 06/08/2010 20/10/2015

NON-IMMUNOSUPPRESSIVE

CYCLOSPORIN FOR THE TREATMENT OF

MUSCULAR DYSTROPHY

DEBIOPHARM S.A. [CH]


OFFICES

297 1/2010/501903 20/08/2010 20/10/2015

PROCESS FOR THE MANUFACTURE OF AT LEAST ONE ETHYLENE

DERIVATIVE COMPOUND

SOLVAY (SOCIETE

ANONYME), [BE]


298 1/2010/501921 24/08/2010 20/10/2015

NUTRITIONAL COMPOSITIONS FOR

PROMOTION OF BONE GROWTH AND

MAINTENANCE OF BONE HEALTH COMPRISING

EXTRACTS OF FOR EXAMPLE ROSEMARY

OR CARAWAY

NESTEC S.A., [CH]


AND ONGSIAKO

299 1/2010/501922 24/08/2010 20/10/2015

POLYPHENOLS FOR THE TREATMENT OF

CARTILAGE DISORDERS

NESTEC S.A. [CH]

SIGUION REYNA, MONTECILLO

AND ONGSIAKO LAW OFFICES

300 1/2010/501924 24/08/2010 20/10/2015

MEDIUM CHAIN DICARBOXYLIC ACIDS,

THEIR DERIVATIVES AND METABOLIC

DISORDERS

NESTEC S.A. [CH]



301 1/2010/501935 25/08/2010 20/10/2015 METHOD FOR PREPARING

COMBRETASTATIN SANOFI-

AVENTIS, [FR]


AQUINO (SAFA LAW)

302 1/2010/502015 03/09/2010 20/10/2015

PHARMACEUTICAL COMPOSITION FOR

PREVENTING DYSBIOSIS

ASSOCIATED WITH ENTERAL

ADMINISTRATION OF ANTIBIOTICS

DIKOVSKIY, ALEKSANDER

VLADIMIROVICH [RU]

SANKAR, SABITA

303 1/2010/502043 07/09/2010 20/10/2015 CRYSTAL OF

BENZIMIDAZOLE COMPOUND

TAKEDA PHARMACEUTIC




304 1/2010/502047 08/09/2010 20/10/2015 CYCLIC COMPOUND AND SALT THEREOF


[JP]



305 1/2010/502063 13/09/2010 20/10/2015

A METHOD FOR THE PRODUCTION OF

HUMAN RECOMBINANT LYSOSOMAL ENZYMES

IN A CEREAL ENDOSPERM

TRANSACTIVA SRL [IT]


GATMAITAN




306 1/2010/502079 13/09/2010 20/10/2015 HIGHLY PURE PENTAMYCIN

LUMAVITA AG [CH]


ASSOCIATES

307 1/2010/502082 14/09/2010 20/10/2015 METHOD AND

APPARATUS FOR THE PLASMA PROCESSING OF FILTER MATERIAL


(INVESTMENTS) LIMITED [UK]



308 1/2010/502105 16/09/2010 20/10/2015 PROCESS FOR

PRODUCING ULTRA-THIN BISCUITS WITH A

SMOOTH SURFACE

GENERALE BISCUIT [FR]


309 1/2010/502109 16/09/2010 20/10/2015

AGENT FOR PREVENTING AND/OR TREATING VASCULAR

DISEASES


[JP]


310 1/2010/502135 17/09/2010 20/10/2015

DETERGENT COMPOSITION

COMPRISING A CO-POLYESTER OF

DICARBOXYLIC ACIDS AND DIOLS

THE PROCTER & GAMBLE

COMPANY [US] SANTOS PILAPIL

AND ASSOCIATES

311 1/2010/502138 17/09/2010 20/10/2015

NITRILE COMPOUND AND ITS USE FOR

CONTROL OF ARTHROPOD PEST

SUMITOMO CHEMICALS COMPANY,

LIMITED [JP]


GATMAITAN

312 1/2010/502158 22/09/2010 20/10/2015

PROCESS FOR THE PREPARATION OF

BENZO-FUSED HETEROARYL DERIVATIVES


A N.V. [BE]

ROMULO MABANTA


DELOS ANGELES

313 1/2010/502173 24/09/2010 20/10/2015 USE OF DEFENSINS AGAINST MENINGITIS

NOVOZYMES ADENIUM

BIOTECH A/S, [DK]

J.V. NATIVIDAD & ASSOCIATES

314 1/2010/502176 24/09/2010 20/10/2015

PROCESS FOR PREPARING ORALLY

ADMINISTERED DABIGATRAN

FORMULATIONS




OFFICES

315 1/2010/502177 24/09/2010 20/10/2015

FLAVOR COMPOSITION CAPABLE OF

IMPARTING COOKED FLAVOR

AJINOMOTO CO., INC. [JP]


OFFICES

316 1/2010/502182 24/09/2010 20/10/2015 CAPSULE FOR THE

PREVENTION OF CARDIOVASCULAR

DISEASES

FERRER INTERNACIONAL, S.A. [ES] AND FUNDACION

CENTRO NACIONAL DE

INVESTIGACIONES

CARDIOVASCULARES CARLOS III

[ES]

JIMENEZ GONZALES

LIWANAG BELLO VALDEZ CALUYA AND FERNANDEZ

(JGLAW)

317 1/2010/502186 24/09/2010 20/10/2015 NOVEL

TETRAHYDROISOQUINOLINE DERIVATIVE

DAIICHI SANKYO COMPANY,

LIMITED [JP]

ORTEGA, BACORRO,

ODULIO, CALMA &




CARBONELL

318 1/2010/502204 28/09/2010 20/10/2015

ORAL AND INJECTABLE FORMULATIONS OF

TETRACYCLINE COMPOUNDS

PARATEK PHARMACEUTICALS, INC. [US]


OFFICES

319 1/2010/502215 29/09/2010 20/10/2015 SUBSTITUTED

ENAMINOTHICARBONYL COMPOUNDS

BAYER CROPSCIENCE

AG [DE]

ORTEGA DEL CASTILLO

BACORRO CALMA & CARBONELL

320 1/2010/502216 29/09/2010 20/10/2015

IMPROVED METHOD FOR PRODUCING

HYDROGEN CYANIDE THROUGH CATALYTIC

DEHYDRATION OF GASEOUS

FORMAMIDE-DIRECT HEATING

BASF SE [DE] E.B. ASTUDILLO AND ASSOCIATES

321 1/2010/502234 01/10/2010 20/10/2015 ISOQUINOLINONE

DERIVATIVES AS NK3 ANTOGONISTS



322 1/2010/502239 01/10/2010 20/10/2015 MATERIALS HAVING

EMBEDDED INSECTICIDES AND

ADDITIVES

BAYER CROPSCIENCE

AG [DE]



323 1/2010/502245 04/10/2010 20/10/2015

LEACHING PROCESS FOR COPPER

CONCENTRATES CONTAINING ARSENIC

AND ANTIMONY COMPOUNDS

THE UNIVERSITY OF BRITISH

COLUMBIA [CA]

DEL ROSARIO & DEL ROSARIO

324 1/2010/502254 04/10/2010 20/10/2015

NOVEL ANTIBODIES AGAINST CANCER

TARGET BLOCK TUMOR GROWTH,

ANGIOGENESIS AND METASTASIS

THE REGENTS OF THE

UNIVERSITY OF CALIFORNIA [US]


325 1/2010/502269 06/10/2010 20/10/2015

AMINOSUGAR COMPOUND AND PROCESS FOR PRODUCTION

THEREOF


[JP] A.Q. ANCHETA

AND PARTNERS

326 1/2010/502270 06/10/2010 20/10/2015 LAUNDRY DETERGENT

CONTAINING SUDS COLLAPSER


COMPANY [US]


327 1/2010/502295 08/10/2010 20/10/2015 PESTICIDAL COMPOSITIONS

BASF CORPORATION

[US]


328 1/2010/502310 12/10/2010 20/10/2015

SULFATED UNSATURATED DISACCHARIDIC CHONDROITIN

SULFATE IN CONNECTIVE TISSUE

PROTECTION AND REPAIR

NESTEC S.A. [CH]


AND ONGSIAKO




329 1/2010/502313 12/10/2010 20/10/2015 4-

DIMETHYLAMINOBUTYRIC ACID DERIVATIVES

F. HOFFMANN-LA ROCHE AG

[CH]


GATMAITAN

330 1/2010/502317 12/10/2010 20/10/2015 COMPOSITIONS FOR THE TREATMENT OF

LICE

SINCLAIR PHARMACEUTIC

ALS LIMITED [GB]

PLATON MARTINEZ

FLOREZ SAN PEDRO AND LEANO LAW

OFFICES

331 1/2010/502327 13/10/2010 20/10/2015


PREPARING AND USING SAME

ARDEA BIOSCIENCES,

INC. [US]



332 1/2010/502332 14/10/2010 20/10/2015 LOXAPINE ANALOGS

AND METHODS OF USE THEREOF

HYPNION, INC., [US]

ROMULO MABANTA


DELOS ANGELES

333 1/2010/502338 15/10/2010 20/10/2015

COMBINATION OF DRONEDARONE WITH

AT LEAST ONE DIURETIC, AND

THERAPEUTIC USE THEREOF

SANOFI-AVENTIS [FR]


AQUINO (SAFA LAW)

334 1/2010/502349 15/10/2010 20/10/2015 MODIFIED FACTOR IX POLYPEPTIDES AND

USES THEREOF


AKTIENGESELLSCHAFT [DE] AND

BAYER HEALTHCARE

LLC [US]

ORTEGA, BACORRO,


335 1/2010/502397 22/10/2010 20/10/2015

PROCESS FOR THE PREPARATION OF 5-(2-

AMINO-PYRIMIDIN-4-YL)-2-ARYL-1H-

PYRROLE-3-CARBOXAMIDES

NERVIANO MEDICAL

SCIENCES S.R.L. [IT]


AND ONGSIAKO

336 1/2010/502398 22/10/2010 20/10/2015 COFFEE EXTRACT NESTEC S.A. [CH]


OFFICES

337 1/2010/502399 22/10/2010 20/10/2015

PRODUCTS COMPRISING, AND

USES OF, DECARBOXYLATED PHENOLIC ACIDS DERIVED FROM

CHLOROGENIC ACIDS OF COFFEE

NESTEC S.A. [CH]


OFFICES

338 1/2010/502402 22/10/2010 20/10/2015

DUAL VARIABLE DOMAIN

IMMUNOGLOBULINS AND USES THEREOF

ABBOTT LABORATORIES,

[US]


GATMAITAN

339 1/2010/502410 22/10/2010 20/10/2015 USE OF

DRONEDARONE FOR PREPARING A

SANOFI-AVENTIS [FR]


AQUINO (SAFA




MEDICAMENT FOR THE TREATMENT OF PATIENTS WITH

ARRHYTHMIA AND HAVING AN INCREASE OF CREATININE LEVEL

DUE TO DRONEDARONE

ADMINISTRATION

LAW)

340 1/2010/502439 28/10/2010 20/10/2015 COMPOUNDS

COMPRISING A CYCLOBUTOXY GROUP

UCB PHARMA, S.A. [BE]



341 1/2010/502460 02/11/2010 20/10/2015

METHODS OF USING CORTICOTROPIN-

RELEASING FACTOR FOR THE TREATMENT

OF CANCER

NEUTRON ROW [BM]


342 1/2010/502468 03/11/2010 20/10/2015 SIALIC ACID TO

SUPPORT THE IMMUNE SYSTEM IN THE

ELDERLY

NESTEC S.A. [CH]

SIGUION REYNA, MONTECILLO & ONGSIAKO LAW

OFFICES

343 1/2010/502502 05/11/2010 20/10/2015 CARBOSTYRIL COMPOUND

OTSUKA PHARMACEUTIC

AL CO., LTD., [JP]

FEDERIS & ASSOCIATES



AG [CH]


345 1/2010/502528 10/11/2010 20/10/2015

NOVEL [F-18] - LABELLED L-GLUTAMIC

ACID-AND- L-GLUTAMINE

DERIVATIVES (I), USE THEREOF AND

METHOD FOR THEIR PRODUCTION





346 1/2010/502539 12/11/2010 20/10/2015 ANTI-FN14 ANTIBODIES AND USES THEREOF

BIOGEN IDEC MA INC. [US]


OFFICES

347 1/2010/502545 12/11/2010 20/10/2015

AMINO ACID SEQUENCES

DIRECTED AGAINST CXCR4 AND OTHER

GPCRS AND COMPOUNDS

COMPRISING THE SAME

ABLYNX N.V. [BE]



348 1/2010/502569 15/11/2010 20/10/2015

IMIDAZO [2,1-B] QUINAZOLIN-2-ONE DERIVATIVES AND

THEIR USE AS PLATELET ANTI-AGGREGATIVE

AGENTS

SHIRE LLC [US] HECHANOVA AND CO. INC.

349 1/2010/502570 15/11/2010 20/10/2015 SUBSTITUTED QUINAZOLINES SHIRE LLC [US] HECHANOVA AND

CO. INC.




350 1/2010/502575 17/11/2010 20/10/2015 IMMUNOMODULATION BY IAP INHIBITORS

DANAFARBER CANCER

INSTITUTE, INC. [US] AND

NOVARTIS AG, [CH]


OFFICES

351 1/2010/502589 18/11/2010 20/10/2015 LIQUID CLEANING

COMPOSITIONS AND MANUFACTURE

COLGATE-PALMOLIVE

COMPANY [US]


GATMAITAN

352 1/2010/502593 18/11/2010 20/10/2015

METHODS AND CATALYSTS FOR

MAKING BIODIESEL FROM THE

TRANSESTERIFICATION AND

ESTERIFICATION OF UNREFINED OILS

WAYNE STATE UNIVERSITY [US]


353 1/2010/502594 19/11/2010 20/10/2015 PROBIOTICS TO IMPROVE GUT MICROBIOTA

NESTEC S.A., [CH]


AND ONGSIAKO

354 1/2010/502602 19/11/2010 20/10/2015

METHOD OF TREATING ANXIOUS MAJOR

DEPRESSIVE DISORDER

ASTRAZENECA AB [SE]


355 1/2010/502612 19/11/2010 20/10/2015 NIACIN AND NSAID FOR

COMBINATION THERAPY

CERENIS THERAPEUTICS HOLDING S.A.

[FR]



356 1/2010/502614 19/11/2010 20/10/2015 AGENT FOR

MAINTENANCE OF INDUCED REMISSION

KYORIN PHARMACEUTIC

AL CO., LTD., [JP]


357 1/2010/502617 22/11/2010 20/10/2015

FLUORO-SUBSTITUTED 3,4-DIARYL-4, 5-

DIHYDRO-1H- PYRAZOLE-1-

CARBOXAMIDINE DERIVATIVES HAVING CB1-ANTAGONISTIC

ACTIVITY

ABBOTT HEALTHCARE

PRODUCTS B.V. [NL]


OFFICES

358 1/2010/502626 23/11/2010 20/10/2015

LACTOBACILLUS HELVETICUS STRAINS

FOR PRODUCING HYPOTENSIVE

PEPTIDES

NESTEC S.A. [CH]


AND ONGSIAKO

359 1/2010/502648 24/11/2010 20/10/2015 AMPHIPHILIC

MOLECULES WITH A TRIAZINE CORE


360 1/2010/502657 25/11/2010 20/10/2015

BROMINE~BASED METHOD AND SYSTEM

FOR CONVERTING GASEOUS ALKANES TO

LIQUID HYDROCARBONS

USING ELECTROLYSIS FOR BROMINE

RECOVERY

MARATHON GTF TECHNOLOGY,

LTD. [US]

ROMULO MABANTA


DELOS ANGELES




361 1/2010/502665 26/11/2010 20/10/2015

DIAMINO-PYRIDINE, PYRIMIDINE, AND

PYRIDAZINE MODULATORS OF THE

HISTAMINE H4 RECEPTOR


A N.V. [BE]

ROMULO MABANTA


DELOS ANGELES

362 1/2010/502676 26/11/2010 20/10/2015

STYRENE MONOMER PROCESS BASED ON

OXIDATIVE DEHYDROGENATION OF ETHYLBENZENE

USING CO2 AS A SOFT OXIDANT

LUMMUS TECHNOLOGY

INC., [US]


363 1/2010/502691 30/11/2010 20/10/2015 ISOQUINOLINONE

DERIVATIVES AS NK3 ANTAGONISTS

H. LUNDBECK A/S, [DK]


364 1/2010/502694 30/11/2010 20/10/2015

PROCESS FOR THE PRODUCTION OF LOW-

CONCENTRATION ETHYLENE FOR CHEMICAL USE

SOLVAY (SOCIETE

ANONYME), [BE]


365 1/2010/502697 30/11/2010 20/10/2015 5-SUBSTITUTED

ISOINDOLINE COMPOUNDS

CELGENE CORPORATION,

[US]



366 1/2010/502699 01/12/2010 20/10/2015 HYDROGENATION OF MULTI-BROMINATED

ALKANES

MARATHON GTF TECHNOLOGY,

LTD. [US]

ROMULO MABANTA


DELOS ANGELES

367 1/2010/502704 02/12/2010 20/10/2015

DUAL VARIABLE DOMAIN

IMMUNOGLOBULINS AND USES THEREOF

ABBOTT LAB0RATORIES

[US]


GATMAITAN

368 1/2010/502707 02/12/2010 20/10/2015 HETEROCYCLIC UREA

DERIVATIVES AND METHODS OF USE

THEREOF

ASTRAZENECA AB [SE]


OFFICES

369 1/2010/502713 02/12/2010 20/10/2015 DETERGENT COMPOSITION


COMPANY [US]


370 1/2010/502714 02/12/2010 20/10/2015 HAND FABRIC LAUNDERING SYSTEM


COMPANY [US] SANTOS PILAPIL

AND ASSOCIATES

371 1/2010/502715 02/12/2010 20/10/2015 HAND FABRIC LAUNDERING METHOD


COMPANY [US]


372 1/2010/502718 02/12/2010 20/10/2015

C-RING-SUBSTITUTED PREGN-4-ENE-21,17-

CARBOLACTONE, AND PHARMACEUTICAL

PREPARATIONS COMPRISING THE

LATTER





373 1/2010/502719 02/12/2010 20/10/2015 TRANSPARENT SILICA

GEL/PRECIPITATED SILICA COMPOSITE

J.M. HUBER CORPORATION

[US]





MATERIALS FOR DENTIFRICES

374 1/2010/502728 03/12/2010 20/10/2015 MULTI-STAGE LEACHING PROCESS

THE UNIVERSITY OF SYDNEY [AU]

ROMULO MABANTA


DELOS ANGELES

375 1/2010/502742 06/12/2010 20/10/2015 AGRICULTURAL

APPLICATIONS OF SILVER DIHYDROGEN

CITRATE

PURE BIOSCIENCE

[US]


GATMAITAN

376 1/2010/502776 09/12/2010 20/10/2015

CALCIUM SALTS OF PHOSPHOROUS ACID FOR INCREASING THE

EFFICACY OF FUNGICIDES


377 1/2010/502801 13/12/2010 20/10/2015 EPROSARTAN COMPOSITIONS

ABBOTT HEALTHCARE

PRODUCTS B.V. [NL]



378 1/2010/502823 14/12/2010 20/10/2015

PROCESS AND APPARATUS FOR

EXTRACTING BIODIESEL FROM

ALGAE

ECHEVARRIA PARRES,

ANTONIO JOSE DE JESUS DE

SAN JUAN BOSCO [MX]

TAW AND ASSOCIATES

379 1/2010/502825 14/12/2010 20/10/2015

METHODS OF CONTROLLING

NEONICOTINOID RESISTANT INSECTS


AG [CH] AND SYNGENTA

LIMITED [GB]


380 1/2010/502826 15/12/2010 20/10/2015

ARTIFICIAL KIDNEY PRECURSOR AND

PROCESS FOR PRODUCTION

THEREOF

OTSUKA PHARMACEUTIC

AL FACTORY, INC. [JP]; JICHI

MEDICAL UNIVERSITY [JP];

TOKYO WOMEN`S MEDICAL

UNIVERSITY [JP] AND THE JIKEI

UNIVERSITY [JP]


OFFICES

381 1/2010/502833 15/12/2010 20/10/2015 NOVEL

PHENYLPYRAZINONES AS KINASE INHIBITORS


[CH]


GATMAITAN

382 1/2010/502858 17/12/2010 20/10/2015

CATALYTIC MATERIALS,

ELECTRODES, AND SYSTEMS FOR WATER ELECTROLYSIS AND

OTHER ELECTROCHEMICAL

TECHNIQUES

SUN CATALYTIX CORPORATION

[US] AND MASSACHUSETTS INSTITUTE OF TECHNOLOGY

[US]

ROMULO MABANTA


DELOS ANGELES

383 1/2010/502859 17/12/2010 20/10/2015 PYRIMIDINE

DERIVATIVES AS KINASE INHIBITORS

IRM LLC [BM] E.B. ASTUDILLO AND ASSOCIATES




384 1/2010/502906 21/12/2010 20/10/2015

ISOINDOLONE DERIVATIVES AS MEK KINASE INHIBITORS

AND METHOD OF USE

GENENTECH, INC. [US]


385 1/2010/502910 21/12/2010 20/10/2015

5- HETEROCYCLYLALKYL

-3- HYDROXY -2- PHENYLCYCLOPENT -

2- ENONES AS HERBICIDES



386 1/2010/502917 22/12/2010 20/10/2015 ORAL FORMULATION H. LUNDBECK A/S [DK]


387 1/2010/502930 28/12/2010 20/10/2015

CRYSTALLINE FORM (2S)-(-)-N-(6-CHLORO-

2,3-DIHYDRO-BENZO[1,4]DIOXIN-2-

YLMETHYL)-SULFAMIDE


A N.V. [BE]

ROMULO MABANTA


DELOS ANGELES

388 1/2010/502932 28/12/2010 20/10/2015 DIFFERENTIATION OF PLURIPOTENT STEM

CELLS


INC. [US]

ROMULO MABANTA


DELOS ANGELES

389 1/2010/502949 28/12/2010 20/10/2015 CYCLOPROPYL POLYMERASE

INHIBITORS

CENTOCOR ORTHO BIOTECH PRODUCTS L.P.

[US] AND MEDIVIR AB [SE]


390 1/2010/502955 29/12/2010 20/10/2015 A METHOD OF LIGHTENING SKIN

UNILEVER N.V. [NL]

OSCAR M. MANAHAN

391 1/2010/502962 29/12/2010 20/10/2015 SILICONE SURFACE-

TREATED MAGNESIUM HYDROXIDE

YAZAKI CORPORATION

[JP]; DOW CORNING

TORAY CO., LTD. [JP] AND

NAGASAKI UNIVERSITY,

NATIONAL UNIVERSITY

CORPORATION [JP]


392 1/2010/502974 30/12/2010 20/10/2015

BICYCLIC HETEROCYCLES AS

MEK KINASE INHIBITORS

GENENTECH, INC. [US]


393 1/2011/000109 05/04/2011 20/10/2015 OPACIFYING

PARTICLES AND COMPOSITIONS

FORMED THEREFROM

ROHM AND HAAS COMPANY,

[US]


394 1/2011/000119 13/04/2011 20/10/2015

PROCESS OF PRODUCING

MOUTHWASH MADE FROM PROPOLIS AND

YERBA BUENA AND MOUTHWASH

PRODUCED THEREOF

MOUNTAIN PROVINCE

STATE POLYTECHNIC

COLLEGE, [PH]

BRENT GREG GOMUAD




395 1/2011/000120 13/04/2011 20/10/2015 METHOD OF

PRODUCING WINE BLENDS

MOUNTAIN PROVINCE

STATE POLYTECHNIC

COLLEGE, [PH]

BRENT GREG GOMUAD

396 1/2011/000133 26/04/2011 20/10/2015

GLASS SUBSTRATE FOR INFORMATION

RECORDING MEDIUM, POLISHING COLLOIDAL

SILICA SLURRY FOR MANUFACTURING THE

SAME AND INFORMATION

RECODING SYSTEM


LIMITED, [JP]


397 1/2011/000172 17/05/2011 20/10/2015 GOAT SEMEN

EXTENDER FORMULATION

ISABELA STATE UNIVERSITY [PH]

AND AUBREY JOY M. BALBIN

[PH]

398 1/2011/000185 25/05/2011 20/10/2015 EMBRYO CULTURE

MEDIUM COMPOSITION FOR SPATHOGLOTTIS AND OTHER ORCHIDS

PHLIPPINE NUCLEAR

RESEARCH INSTITUTE (PNRI) [PH]

NOEL A. CATIBOG

399 1/2011/500015 03/01/2011 20/10/2015 TNF-A ANTAGONIST

MULTI-TARGET BINDING PROTEINS

EMERGENT PRODUCT

DEVELOPMENT SEATTLE, LLC

[US]


OFFICES

400 1/2011/500032 05/01/2011 20/10/2015

PLANT EXPRESSION CONSTRUCTS

COMPRISING AND USES THEREOF

MORFLORA ISRAEL LTD. [IL]

AND YISSUM RESEARCH

DEVELOPMENT COMPANY OF THE HEBREW

UNIVERSITY OF JERUSALEM,

LTD. [IL]


401 1/2011/500040 07/01/2011 20/10/2015

ENZYMES AND METHODS FOR HYDROLYSING PHENYLUREAS,

CARBAMATES AND ORGANOPHOSPHATES

COMMONWEALTH SCIENTIFIC

AND INDUSTRIAL RESEARCH

ORGANISATION [AU]


GATMAITAN

402 1/2011/500050 07/01/2011 20/10/2015 FGF-R4 RECEPTOR-

SPECIFIC ANTAGONISTS



AQUINO (SAFA LAW)

403 1/2011/500133 19/01/2011 20/10/2015




REP2 POLYPEPTIDES AND HOMOLOGS

E.I. DU PONT DE NEMOURS AND COMPANY [DE] AND PIONEER


INC. [US]






THEREOF

404 1/2011/500177 25/01/2011 20/10/2015 5-ALKYNYL-PYRIMIDINES




OFFICES

405 1/2011/500189 26/01/2011 20/10/2015 NITROGENATED DERIVATIVES OF PANCRATISTATIN

PIERRE FABRE MEDICAMENT

[FR]

ROMULO MABANTA


DELOS ANGELES

406 1/2011/500195 26/01/2011 20/10/2015 PROCESS FOR PREPARING EBASTINE

MICRO LABS LIMITED [IN]

ANGARA ABELLO CONCEPCION

REGALA & CRUZ LAW OFFICES

407 1/2011/500203 27/01/2011 20/10/2015

GUM ARABIC REPLACEMENTS IN: 1)

PLANNING, CONFECTIONS,

ADHESION & COATINGS; 2) EDIBLE FILMS AND FLAVOR

ENCAPSULATION; AND 3) LITHOGRAPHY

TIC GUMS, INC. [US]


408 1/2011/500205 27/01/2011 20/10/2015 LIQUID FUEL COMPOSITIONS

SHELL INTERNATIONAL

E RESEARCH MAATSCHAPPIJ

B.V. [NL]



409 1/2011/500223 28/01/2011 20/10/2015

EXTRACTION OF URANIUM FROM WET-

PROCESS PHOSPHORIC ACID

URTEK LLC [US] VILLARAZA CRUZ

MARCELO & ANGANGCO

410 1/2011/500225 28/01/2011 20/10/2015 LIQUID FUEL COMPOSITIONS

SHELL INTERNATIONAL

E RESEARCH MAATSCHAPPIJ

B.V. [NL]

411 1/2011/500233 31/01/2011 20/10/2015 PYRROLIDIN-2-ONES AS HDM2 LIGANDS

PRIAXON AG [DE]


412 1/2011/500240 02/02/2011 20/10/2015 METHODS OF

TREATING THALASSEMIA

TARGEGEN, INC. [US]


AQUINO (SAFA LAW)

413 1/2011/500248 02/02/2011 20/10/2015 TREATMENT OF

PULMONARY ARTERIAL HYPERTENSION

NOVARTIS AG [CH]

E.B. ASTUDILLO & ASSOCIATES

414 1/2011/500263 04/02/2011 20/10/2015

MICROCAPSULES IN SURFACTANT-CONTAINING

COMPOSITIONS

UNILEVER N.V. [NL]

OSCAR M. MANAHAN

415 1/2011/500264 04/02/2011 20/10/2015

CYCLOHEXYL AMIDE DERIVATIVES AND

THEIR USE AS CRF-1 RECEPTOR

ANTAGONISTS

NOVARTIS AG [CH]


416 1/2011/500274 07/02/2011 20/10/2015 ENGINEERED ANTI-IL-13 ANTIBODIES,


ROMULO MABANTA




COMPOSITIONS, METHODS AND USES

INC. [US] BUENAVENTURA SAYOC AND

DELOS ANGELES



AND SYNGENTA PARTICIPATIONS

AG [CH]


418 1/2011/500341 15/02/2011 20/10/2015

METHODS AND SYSTEMS FOR PREDICTING

RESPONSE TO CELLS TO A THERAPEUTIC

AGENT

MERRIMACK PHARMACEUTIC

ALS, INC. [US]


OFFICES

419 1/2011/500468 04/03/2011 20/10/2015

IMPROVEMENTS IN THE ABSORPTION OF

THERAPEUTIC AGENTS ACROSS MUCOSAL

MEMBRANES OR THE SKIN

CRITICAL PHARMACEUTIC

ALS LIMITED [GB]


420 1/2011/500475 07/03/2011 20/10/2015

GLUCOCORTICOID RECEPTOR AGONIST COMPRISING NOVEL

1,2,3,4- TETRAHYDROQUINOXA

LINE DERIVATIVES CONTAINING PHENYL

GROUP HAVING SULFONIC ACID ESTER

STRUCTURE INTRODUCED THEREIN

AS SUBSTITUENT

SANTEN PHARMACEUTICAL CO., LTD. [JP]


OFFICES

421 1/2011/500486 08/03/2011 20/10/2015

PYRAZOLOPYRIMIDINES AND THEIR USE FOR THE TREATMENT OF

CNS DISORDERS




OFFICES

422 1/2011/500499 10/03/2011 20/10/2015


TREATMENT OF DIABETES AND

RELATED CONDITIONS




OFFICES

423 1/2011/500521 11/03/2011 20/10/2015

STABLE PHARMACEUTICAL

FORMULATION WITH LIMITED

DISCOLORATION

DAIICHI SANKYO HEALTHCARE CO., LTD. [JP]



424 1/2011/500586 21/03/2011 20/10/2015 NOVEL FUSED

AMINODIHYDROTHIAZINE DERIVATIVE

EISAI R & D MANAGEMENT CO., LTD. [JP]


425 1/2011/500678 01/04/2011 20/10/2015 HIV INTEGRASE INHIBITORS


[US] HECHANOVA AND

CO. INC.

426 1/2011/500679 01/04/2011 20/10/2015

SYSTEMIC TREATMENT OF BLOOD-SUCKING

AND BLOOD-CONSUMING

PARASITES BY ORAL ADMINISTRATION OF A

BAYER B.V. [NL]




PARASITICIDAL AGENT

427 1/2011/500704 07/04/2011 20/10/2015 WHEY PROTEIN COMPOSITIONS,

METHODS AND USES

NESTEC S.A. [CH]

428 1/2011/500716 08/04/2011 20/10/2015 SUSTAINED RELEASE

DRUG DELIVERY SYSTEM

BIOPLUS LIFE SCIENCES PVT

LTD. [IN]


ASSOCIATES

429 1/2011/500749 14/04/2011 20/10/2015

FUSED, SPIROCYCLIC HETEROAROMATIC

COMPOUNDS FOR THE TREATMENT OF

BACTERIAL INFECTIONS

ASTRAZENECA AB [SE]


OFFICES

430 1/2011/500835 29/04/2011 20/10/2015 CONCENTRATED SHAMPOO

UNILEVER N.V. [NL]

OSCAR M. MANAHAN

431 1/2011/500836 29/04/2011 20/10/2015 COMPOUNDS HAVING

TAFIA INHIBITORY ACTIVITY

TAISHO PHARMACEUTICAL CO., LTD. [JP]


OFFICES

432 1/2011/500840 29/04/2011 20/10/2015

DISUBSTITUTED PHTHALAZINE

HEDGEHOG PATHWAY ANTAGONISTS

ELI LILLY AND COMPANY [US]

AGCAOILI ASSOCIATES

433 1/2011/500847 03/05/2011 20/10/2015

MULTICOMPONENT IMMUNOGENIC

COMPOSITION FOR THE PREVENTION OF

BETAHEMOLYTIC STREPTOCOCCAL

(BHS) DISEASE

WYETH LLC [US] SYCIP SALAZAR

HERNANDEZ AND GATMAITAN

434 1/2011/500851 04/05/2011 20/10/2015 CRHR2 PEPTIDE

AGONISTS AND USES THEREOF


A N.V. [BE]

ROMULO MABANTA


DELOS ANGELES

435 1/2011/500883 09/05/2011 20/10/2015 SALTS OF FIGOLIMOD NOVARTIS AG [CH]


436 1/2011/500918 12/05/2011 20/10/2015 NAPHTHYLACETIC ACIDS

F. HOFFMANN - LA ROCHE AG

[CH]


GATMAITAN

437 1/2011/500931 16/05/2011 20/10/2015

[4-(1-AMINO-ETHYL)-CYCLOHEXYL]-

METHYL-AMINES AS ANTIBACTERIALS

ASTRAZENECA AB [SE]


OFFICES

438 1/2011/500978 19/05/2011 20/10/2015

GLYCOGEN SYNTHASE KINASE-3 BETA

INHIBITORS CONTAINING 7-

HYDROXY - BENZOIMIDAZOLE-4-

YL-METHANONE DERIVATIVES

ONCOTHERAPY SCIENCE, INC.

[JP]


BULILAN LAW OFFICES

439 1/2011/501043 27/05/2011 20/10/2015

CARBOXYLIC ACID DERIVATIVE

CONTAINING THIAZOLE RING AND

PHARMACEUTICAL


CORPORATION [JP]

SIGUION REYNA MONTECILLO &

ONGSIAKO




USE THEREOF

440 1/2011/501068 30/05/2011 20/10/2015 BIDIRECTIONAL

PROMOTER FROM Z. MAIS

BASF PLANT SCIENCE GMBH

[DE]


441 1/2011/501108 02/06/2011 20/10/2015 ORGANIC COMPOUNDS

INTRA-CELLULAR

THERAPIES, INC. [US]

442 1/2011/501109 02/06/2011 20/10/2015 ORGANIC COMPOUNDS

INTRA-CELLULAR

THERAPIES, INC. [US]

443 1/2011/501150 09/06/2011 20/10/2015

4-AZETIDINYL-1-HETEROARYL-

CYCLOHEXANOL ANTAGONISTS OF

CCR2


A N.V. [BE]

ROMULO MABANTA


DELOS ANGELES

444 1/2011/501175 10/06/2011 20/10/2015 ANTAGONISTS OF

LYSOPHOSPHATIDIC ACID RECEPTORS

AMIRA PHARMACEUTICALS, INC. [US]


445 1/2011/501238 16/06/2011 20/10/2015 TREATMENT OF

DYSKINESIA RELATED DISORDERS



446 1/2011/501256 17/06/2011 20/10/2015 MYOSTATIN BINDING PROTEINS

GLAXO GROUP LIMITED [UK]


OFFICES

447 1/2011/501258 17/06/2011 20/10/2015 PHENAZOPYRIDINE COMPOUNDS

PINNACLE PHARMACEUTIC

ALS, INC. [US]


OFFICES

448 1/2011/501270 17/06/2011 20/10/2015

ONE-STEP PROESS FOR PREPARING

PALIPERIDONE AND ITS OXALATE SALT

CHEMO IBÉRICA, S.A. [ES]

JIMENEZ GONZALES


(JGLAW)

449 1/2011/501277 21/06/2011 15/10/2015

AROYLAMINO-AND HETEROAROYLAMINO-

SUBSTITUTED PIPERIDINES AS GLYT-

1 INHIBITORS

EMMANUEL PINARD [FR];

HENRI STALDER [CH] AND SABINE

KOLCZEWSKI [DE]


GATMAITAN

450 1/2011/501290 22/06/2011 20/10/2015

METHODS AND COMPOSITIONS

RELATED TO THIOESTERASE

ENZYMES

LS9, INC. [US] PATRICK

MIRANDAH CO. PHILIPPINES, INC.

451 1/2011/501297 22/06/2011 20/10/2015 NUCLEOSIDE PHOSPHORAMIDATES

GILEAD PHARMASSET

LLC [US] E.B. ASTUDILLO

AND ASSOCIATES

452 1/2011/501319 23/06/2011 20/10/2015


OPTICALLY ACTIVE COMPOUNDS USING

TRANSFER HYDROGENATION

NOVARTIS AG [CH]





453 1/2011/501331 27/06/2011 20/10/2015

DERIVATIVES OF 2-PYRIDIN-2-YL-

PYRAZOL-3(2H)-ONE, PREPARATION AND THEAPEUTIC USE THEREOF AS HIF

ACTIVATORS

SANOFI [FR] SALUDO

FERNANDEZ AND AQUINO (SAFA

LAW)

454 1/2011/501336 28/06/2011 20/10/2015 SUBSTITUTED QUINAZOLINE COMPOUNDS

FOVEA PHARMACEUTIC

ALS [FR]

QUISUMBING TORRES LAW

OFFICES

455 1/2011/501356 04/07/2011 20/10/2015

PHARMACEUTICAL COMPOSITIONS

COMPRISING A HCV POLYMERASE

INHIBITOR PRODRUG


[CH]


GATMAITAN

456 1/2011/501374 07/07/2011 20/10/2015 METHODS OF

DIAGNOSING AND TREATING DYSPHAGIA

NESTEC S.A. [CH]


OFFICES

457 1/2011/501395 11/07/2011 20/10/2015 COMBINATIONS

COMPRISING METHOTREXATE AND DHODH INHIBITORS

ALMIRALL S.A. [ES]


GATMAITAN

458 1/2011/501401 12/07/2011 20/10/2015

QUINAZOLINONE DERIVATIVES USEFUL

AS VANILLOID ANTAGONISTS

NOVARTIS AG [CH]


459 1/2011/501442 18/07/2011 20/10/2015

PURIFICATION OF 1-[2-(2,4-

DIMETHYLPHENYLSULFANYL)PHENYL]PIPERA

ZINE



460 1/2011/501450 19/07/2011 20/10/2015

NEW COMBINATION OF ACTIVE INGREDIENTS CONTAINING A NON

STEROIDAL ANTI INFLAMMATORY DRUG AND A COLCHICOSIDE

DERIVATIVE

SANOFI [FR]


AQUINO (SAFA LAW)

461 1/2011/501470 27/06/2011 20/10/2015

CELLULOLYTIC POLYPEPTIDES AND

THEIR USE IN MICRO-ORGANISMS FOR THE

PRODUCTION OF SOLVENTS AND FUELS

TOTAL RAFFINAGFE MARKETING

[FR]



462 1/2011/501471 21/07/2011 20/10/2015 IL-1 BINDING PROTEINS

ABBOTT LABORATORIES

[US]


GATMAITAN

463 1/2011/501480 21/07/2011 20/10/2015 AMIDE DERIVATIVES

AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS



464 1/2011/501569 04/08/2011 20/10/2015 DIHYDROQUINOLINONE DERIVATIVES

TAISHO PHARMACEUTICAL CO., LTD. [JP]


OFFICES

465 1/2011/501657 18/08/2011 20/10/2015 5-(2-{[6-(2, 2-DIFLUORO-

2-PHENYLETHOXY)HEXY

ALMIRALL, S.A. [ES]


GATMAITAN




L]AMINO}-L-HYDROXYETHYL)-8-

HYDROXYQUINOLIN-2 (1H)-ONE AND ITS USE IN THE TREATMENT OF

PULMONARY DISEASES

466 1/2011/501673 22/08/2011 20/10/2015

ADDITION SALTS OF TROMETHAMINE WITH

AZABIPHENYLAMINOBENZOIC ACID

DERIVATIVES AS DHODH INHIBITORS

ALMIRALL, S.A. [ES]


GATMAITAN

467 1/2011/501854 16/09/2011 20/10/2015 AMIDE DERIVATIVE DAIICHI SANKYO

COMPANY, LIMITED [JP]



468 1/2011/502055 10/10/2011 20/10/2015 INHIBITORS OF HIV REPLICATION




OFFICES

469 1/2011/502056 10/10/2011 20/10/2015

THIAZOLE DERIVATIVES AND

THEIR USE AS P2Y12 RECEPTOR

ANTAGONISTS

ACTELION PHARMACEUTICALS LTD [CH]


GATMAITAN

470 1/2011/502113 17/10/2011 20/10/2015

PHARMACEUTICALLY ACTIVE

COMPOSITIONS COMPRISING

OXIDATIVE STRESS MODULATORS (OSM),

NEW CHEMICAL ENTITIES,

COMPOSITIONS AND USES

COLBY PHARMACEUTIC

AL COMPANY [US]


471 1/2011/502125 19/10/2011 20/10/2015 METHODS OF

TREATMENT FOR SOLID TUMORS

GILEAD CALISTOGA LLC

[US]


472 1/2011/502403 17/11/2011 20/10/2015

SUBSTITUTED AMINOBUTYRIC

DERIVATIVES AS NEPRILYSIN INHIBITORS

NOVARTIS AG [CH]


473 1/2011/502434 21/11/2011 20/10/2015

NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE

TREATMENT OF CANCER AND

FURTHER DISEASES

ASTRAZENECA AB [SE] AND DAINIPPON SUMITOMO

PHARMA CO., LTD [JP]


474 1/2011/502463 24/11/2011 20/10/2015

TRIAZOLE COMPOUNDS

CARRYING A SULFUR SUBSTITUENT


475 1/2011/502477 25/11/2011 20/10/2015 SUBSTITUTED PIPERIDINES

BAYER PHARMA AG [DE]






476 1/2011/502489 28/11/2011 20/10/2015 PYRAZINYLPYRAZOLES

BAYER CROPSCIENCE

AG [DE]



477 1/2011/502491 29/11/2011 20/10/2015

2, 4-DIAMINOPYRIMIDINES FOR THE TREATMENT

OF DISEASES CHARACTERISED BY

EXCESSIVE OR ABNORMAL CELL PROLIFERATION




OFFICES

478 1/2011/502512 01/12/2011 20/10/2015 17BETA-ALKYL-17 A-OXY-ESTRATRIENES

BAYER PHARMA AKTIENGESELLS

CHAFT [DE]

479 1/2011/502531 05/12/2011 20/10/2015 AMINOPYRROLIDINONE DERIVATIVES AND

USES THEREOF

LINK MEDICINE CORPORATION

[US]



480 1/2011/502633 19/12/2011 20/10/2015 VACCINES AND

METHODS TO TREAT CANINE INFLUENZA

ZOETIS P LLC [US]


481 1/2012/000110 11/05/2012 20/10/2015

THE PROCESS AND COMPOSITION FOR

KILLING NEMATODES AND WEEDS IN SOILS

RAJAMMANAN, AMBROSE

HARRY J. [PH]

THE LANANG LAW OFFICE OF ATTY. KENNETH

L. DABI

482 1/2012/000123 22/05/2012 20/10/2015

DIVALENT CATION CONTAINING


TREATING AND/OR PREVENTING ENZYMATIC IRRITATION

JOHNSON & JOHNSON

CONSUMER COMPANIES,

INC. [US]

ROMULO MABANTA


DELOS ANGELES

483 1/2012/000153 11/06/2012 20/10/2015

DIVALENT CATION/TALC CONTAINING



JOHNSON AND JOHNSON

CONSUMER COMPANIES,

INC. [US]

ROMULO MABANTA


ANGELES

484 1/2012/000176 21/06/2012 20/10/2015

ZINC OXIDE/ACID CONTAINING



JOHNSON & JOHNSON

CONSUMER COMPANIES,

INC. [US]

ROMULO MABANTA

BUENAVENTURA SAYOC & DELOS

ANGELES

485 1/2012/000291 28/09/2012 20/10/2015 MUTANT INBRED CORN LINE AYI5096

LAURENA, ANTONIO C., ET.

AL. [PH]

JASON G. BARANDA

AND/OR MOLO SIA VELASCO




TUAZON & TY LAW OFFICES

486 1/2012/500023 04/01/2012 20/10/2015 BACE INHIBITORS ELI LILLY AND COMPANY [US]

AGCAOILI ASSOCIATES

487 1/2012/500088 13/01/2012 20/10/2015 GPR119 AGONISTS ELI LILLY AND COMPANY [US]

AGCAOILI ASSOCIATES

488 1/2012/500153 24/01/2012 20/10/2015 SIGNALING

CHARACTERISTICS OF AN MVC OPERATION

POINT

QUALCOMM INCORPORATED

[US]

ROMULO MABANTA


ANGELES

489 1/2012/500170 26/01/2012 20/10/2015

FULVESTRANT IN A DOSAGE OF 500MG

FOR THE TREATMENT OF ADVANCED BREAST

CANCER

ASTRAZENECA AB [SE]

ORBOS CABUSORA &

TAGUIAM

490 1/2012/500176 26/01/2012 20/10/2015 PACKAGE AND METHOD FOR

PRODUCING SAME

LOTTE CO., LTD [JP]

PATRICK MIRANDAH CO.

PHILIPPINES, INC.

491 1/2012/500212 01/02/2012 20/10/2015 NITROGENOUS-RING

ACYLGUANIDINE DERIVATIVE


[JP]


492 1/2012/500407 27/02/2012 20/10/2015 NOVEL

TETRAHYDROISOQUINOLINE COMPOUNDS

DAIICHI SANKYO COMPANY,

LIMITED [JP]

ORTEGA, BACORRO,


493 1/2012/500497 09/03/2012 20/10/2015

SUBSTITUTED (HETEROARYLMETHYL) THIOHYDANTOINS AS ANTICANCER DRUGS

BAYER PHARMA AKTIENGESELLS

CHAFT [DE]

ORTEGA, BACORRO,


494 1/2012/500570 21/03/2012 20/10/2015 2-OXO-1-

PYRROLIDINYL IMIDAZOTHIADIAZOLE

DERIVATIVES

UCB PHARMA, S.A. [BE]


OFFICES

495 1/2012/500572 21/03/2012 20/10/2015

POLYCYCLIC COMPOUNDS AS

LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS

AMIRA PHARMACEUTICALS, INC. [US]


OFFICES

496 1/2012/500739 16/04/2012 20/10/2015

USE OF BFIDOBACTERIUM LONGUM FOR THE PREVENTION AND

TREATMENT OF INFLAMMATION

NESTEC S.A. [CH]


OFFICES

497 1/2012/500852 30/04/2012 20/10/2015

ACYLAMINO-SUBSTITUTED CYCLIC

CARBOXYLIC ACID DERIVATIVES AND

THEIR USE AS PHARMACEUTICALS

SANOFI [FR] CESAR C. CRUZ & PARTNERS

498 1/2012/500863 30/04/2012 20/10/2015

2-AMINO-9-[4-(4-METHOXY-PHENOXY)-

PIPERIDIN-1-YL]-4-PHENYL-INDENO[1,2-D]PYRIMIDIN-5-ONE AND ITS USE AS A

HIGHLY SELECTIVE


A NV [BE]

ROMULO MABANTA


ANGELES




ADENOSINE A2A RECEPTOR

ANTAGONIST

499 1/2012/500922 09/05/2012 20/10/2015 HEPATITIS C VIRUS INHIBITORS


COMPANY [US]


OFFICES

500 1/2012/500953 14/05/2012 20/10/2015

PROCESS FOR PREPARING A

POLYMORPH OF THE CHOLINE SALT OF A

PYRIMIDIN-5-YL ACETIC ACID DERIVATIVE




OFFICES

501 1/2012/500958 14/05/2012 20/10/2015

PROCESS FOR PREPARING 4-NITRO-

OXY-METHYL-BENZOIC ACID

FERRER INTERNACIONAL, S.A. [ES] AND

NICOX S. A. [FR]

JIMENEZ GONZALES


(JGLAW)

502 1/2012/501004 22/05/2012 20/10/2015

PYRIDINE-PYRIDINONE DERIVATIVES,

PREPARATION AND THERAPEUTIC USE

THEREOF

SANOFI [FR]

SALUDO FERNANDEZ

AQUINO & TALEON LAW

OFFICES

503 1/2012/501007 22/05/2012 20/10/2015

PYRAZINE DERIVATIVES AND THEIR USE IN THE

TREATMENT OF NEUROLOGICAL

DISORDERS

NOVARTIS AG [CH]

E.B. ASTUDILLO & ASSOCIATES

504 1/2012/501022 24/05/2012 20/10/2015

METHOD FOR PRODUCING METHYL - {4, 6-DIAMINO -2-[1- (2-FLUOROBENZYL) -1H-

PYRAZOLO [3,4-B] PYRIDINO -3-YL]

PYRIMIDINO -5-YL} CARBAMATE AND ITS PURIFICATION FOR USE THEREOF AS PHARMACEUTICAL

SUBSTANCE

BAYER INTELLECTUAL

PROPERTY GMBH [DE]

ORTEGA, BACORRO,


505 1/2012/501029 25/05/2012 20/10/2015 SPIROINDOLINONE PYRROLIDINES


[CH]


GATMAITAN

506 1/2012/501052 28/05/2012 20/10/2015 NOVEL

SPIROPIPERIDINE COMPOUNDS

ELI LILLY AND COMPANY [US]

AGCAOILI ASSOCIATES

507 1/2012/501053 28/05/2012 20/10/2015

NEW AZABICYCLO[3.1.0]HEX-

2-YL COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL

COMPOSITIONS CONTAINING THEM

LES LABORATOIRES

SERVIER [FR]





508 1/2012/501147 11/06/2012 20/10/2015

IMPROVED BLENDS OF POLYARYLENE ETHERS AND

POLYARYLENE SULFIDES


509 1/2012/501153 11/06/2012 15/10/2015

PROCESS FOR SYNTHESIS OF

INTERMEDIATES USEFUL FOR MAKING

SUBSTITUTED INDAZOLE AND AZAINDAZOLE COMPOUNDS




OFFICES

510 1/2012/501237 18/06/2012 20/10/2015

(METHYLSULFONYL) ETHYL BENZENE

ISOINDOLINE DERIVATIVES AND

THEIR THERAPEUTIC USES

CELGENE CORPORATION

[US] HECHANOVA AND

CO. INC.

511 1/2012/501361 02/07/2012 20/10/2015 TRICYCLIC

COMPOUNDS FOR USE AS KINASE INHIBITORS

CENTRO NACIONAL DE

INVESTIGACIONES

ONCOLOGICAS (CNIO) [ES]

HECHANOVA & CO. INC.

512 1/2012/501381 06/07/2012 20/10/2015

NOVEL SUBSTITUTED BICYCLIC TRIAZOLE

DERIVATIVES AS GAMMA SECRETASE

MODULATORS


ALS, INC. [US]

HECHANOVA & CO. INC.

513 1/2012/501476 18/07/2012 20/10/2015 AMINOQUINOLINE DERIVATIVES

CONCERT PHARMACEUTIC

ALS, INC. [US] E.B. ASTUDILLO

AND ASSOCIATES

514 1/2012/501521 25/07/2012 20/10/2015

5-ALKYNYL PYRIMIDINES AND

THEIR USE AS KINASE INHIBITORS




OFFICES

515 1/2012/501556 31/07/2012 20/10/2015 SUBSTITUTED

NAPHTHALENYL-PYRIMIDINE

COMPOUNDS

ARQULE, INC. [US]

DEL ROSARIO BAGAMASBAD &

RABOCA LAW OFFICE

516 1/2012/501625 10/08/2012 20/10/2015


ISOXAZOLINE DERIVATIVES


AG [CH]


517 1/2012/501637 14/08/2012 20/10/2015

HETEROARYL PYRROLIDINYL AND

PIPERIDINYL DETONE DERIVATIVES


[CH]


GATMAITAN

518 1/2012/501781 07/09/2012 20/10/2015 TREATMENTS USING CITRULLINE

NESTEC S.A. [CH]


OFFICES

519 1/2012/501798 10/09/2012 20/10/2015

USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR THE

SANOFI [FR]

SALUDO FERNANDEZ

AQUINO & TALEON LAW

OFFICES




PREPARATION OF A MEDICAMENT FOR ADMINISTRATION SHORTLY AFTER

AMIODARONE DISCONTINUATION

520 1/2012/501817 12/09/2012 20/10/2015

POLYSUBSTITUTED DERIVATIVES OF 6-

HETEROARYL-IMIDAZO[1,2-A]

PYRIDINES, AND PREPARATION AND THERAPEUTIC USE

THEREOF

SANOFI-AVENTIS [FR]

SALUDO AGPALO FERNANDEZ &

AQUINO

521 1/2012/501853 19/09/2012 20/10/2015

PYRIMIDINYLPIPERIDINYLOXYPYRIDINONE

ANALOGUES AS GPR119 MODULATORS


COMPANY [US]


OFFICES

522 1/2012/501907 25/09/2012 20/10/2015 ADENOSINE

COMPOUNDS AND THIER USE THEREOF

INOTEK PHARMACEUTIC

ALS CORPORATION

[US]


523 1/2012/502167 05/11/2012 20/10/2015 ANTI-INFLAMMATORY AGENTS


INTERNATIONAL GMBH [DE] AND

CAMBRIDGE ENTERPRISE LIMITED [GB]


OFFICES

524 1/2012/502169 05/11/2012 20/10/2015 ANTI-INFLAMMATORY AGENTS


INTERNATIONAL GMBH [DE] AND

CAMBRIDGE ENTERPRISE LIMITED [GB]


OFFICES

525 1/2012/502339 27/11/2012 20/10/2015 AMIDO-TROPANE DERIVATIVES


[CH]


GATMAITAN

526 1/2012/502373 29/11/2012 20/10/2015 AMINOPYRIMIDINE DERIVATIVES AS

LRRK2 MODULATORS


[CH]


GATMAITAN

527 1/2012/502379 29/11/2012 20/10/2015

5-AMINO-3,6-DIHYDRO-1H-PYRAZIN-2-ONE

DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE

(BACE)


A NV [BE] HECHANOVA &

CO., INC.

528 1/2012/502427 06/12/2012 20/10/2015

PROCESS FOR PREPARING

CRYSTALLINE 3,6,9-TRIAZA-3,6,9-

TRIS(CARBOXYMETHYL)-4-(4-

ETHOXYBENZYL)UNDECANEDIOIC ACID AND

USE FOR PRODUCTION

BAYER INTELLECTUAL

PROPERTY GMBH [DE]

ORTEGA BACORRO





OF PRIMOVIST

529 1/2012/502469 13/12/2012 20/10/2015 SUBSTITUTED TRIAZOLOPYRIDINES

BAYER INTELLECTUAL

PROPERTY GMBH [DE]

ORTEGA, BACORRO,


530 1/2013/500581 26/03/2013 20/10/2015 PHARMACEUTICAL COMBINATIONS

NOVARTIS AG [CH]


531 1/2013/500713 12/04/2013 20/10/2015 ANTITUSSIVE

COMPOSITIONS COMPRISING MEMANTINE

THE JOHNS HOPKINS

UNIVERSITY [US] AND CERECOR

INC. [US]

DREWMARKS PHILIPPINES, INC.

532 1/2013/500880 02/05/2013 20/10/2015

PYRAZOLE AMINOPYRIMIDINE DERIVATIVES AS

LRRK2 MODULATORS

F. HOFFMANN-LA-ROCHE AG

[CH]


GATMAITAN

533 1/2013/501258 17/06/2013 20/10/2015 SUBSTITUTED

PYRIDINES AS SODIUM CHANNEL BLOCKERS

PURDUE PHARMA L.P.

[US]


ASSOCIATES

534 1/2013/501421 28/06/2013 20/10/2015 DIBENZOTHIAZEPINE

DERIVATIVES AND USE THEREOF

ASTRAZENECA AB [SE]

ORBOS CABUSORA

TAGUIAM LAW OFFICE

535 1/2013/501515 17/07/2013 20/10/2015

FUSED DIHYDROFURANS AS

GPR119 MODULATORS FOR THE TREATMENT

OF DIABETES, OBESITY AND RELATED DISORDERS



CASTILLO LAMAN TAN PANTALEON

& SAN JOSE

number: vol 18 no. 112 date released: october 21, 2015

Documents